Follow-up examination after treatment for conditions other than malignant neoplasms

Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z09 Cause of death: ICD-10 — Z09 2 out of 7 registries used, show all original rules.	35509
4. Check minimum number of events None	35509
5. Include endpoints None	35509
6. Filter based on genotype QC (FinnGen only)	34346

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[0-1]

NAME	Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z09
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z09
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Follow-up examination after treatment for conditions other than malignant neoplasms based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	34346	27582	6764
Unadjusted period prevalence (%)	8.47	9.78	3.10
Median age at first event (years)	50.45	48.44	58.66

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
28131: Matched controls
186144

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JAH01

NOMESCO Finland

Laparoscopy

3.4

322.0

1345

2684

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

321.1

9821

45049

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

319.9

1848

4497

S42.2

ICD-10 Finland

Fracture of upper end of humerus

3.3

316.9

1428

2995

Z00.8

ICD-10 Finland

Other general examinations

3.0

313.4

1622

3705

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

7.6

312.2

540

476

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

311.4

2285

6298

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

310.6

17702

94701

M01AE02

ATC

naproxen; oral, rectal

1.6

310.5

14729

75293

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

3.0

310.5

1667

3890

J01FF01

ATC

clindamycin; systemic

1.8

310.2

6473

26610

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

309.7

3685

12522

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

6.1

307.7

3419

4140

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.8

307.7

1596

2888

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.4

307.7

3319

9662

M01AH05

ATC

etoricoxib; oral

1.7

307.7

15927

80889

LCD10

NOMESCO Finland

Vaginal hysterectomy

5.4

307.7

1337

1693

J01AA02

ATC

doxycycline; systemic

1.8

307.7

19955

107741

L15

ICPC

Knee symptom/complaint

1.9

307.7

5844

22688

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.3

307.7

3304

7216

Z30.2

ICD-10 Finland

Sterilization

2.7

307.7

3103

8303

S18

ICPC

Laceration/cut

1.9

307.7

11229

48241

Z01.0

ICD-10 Finland

Examination of eyes and vision

12.2

307.7

3520

2163

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

307.7

3867

12742

Z01.2

ICD-10 Finland

Dental examination

1.7

307.7

11887

56479

X58

ICD-10 Finland

Exposure to other specified factors

2.4

307.7

3984

11963

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.1

307.7

2232

3814

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

11129

47631

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

307.7

4338

15001

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

307.7

2093

5211

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

307.7

4069

13769

W19

ICD-10 Finland

Unspecified fall

2.5

307.7

2727

7677

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

3.4

307.7

1495

3044

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

307.7

7962

31127

XLA10, ,

NOMESCO Finland

3.5

307.7

1558

3074

Z50.1

ICD-10 Finland

Other physical therapy

3.9

307.7

1492

2616

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

391.6

307.7

2032

R51.80

ICD-10 Finland

Headache

2.4

307.7

3933

11793

TQW40

NOMESCO Finland

Remowal of suture of skin

3.1

307.7

2198

4930

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

307.7

4385

15101

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

380.7

307.7

1264

L13

ICPC

Hip symptom/complaint

2.1

307.7

4277

14916

N39.3

ICD-10 Finland

Stress incontinence

4.5

307.7

2874

4543

N05AH04

ATC

quetiapine; oral

2.1

307.7

4044

13941

N02BE01

ATC

paracetamol; systemic, rectal

3.0

307.7

24917

133655

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

6.8

307.7

1759

1798

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.8

307.7

2398

4425

R42

ICD-10 Finland

Dizziness and giddiness

2.0

307.7

5236

19134

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

307.7

7315

28842

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.7

307.7

2389

6298

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

4.2

307.7

1768

2951

Z01.1

ICD-10 Finland

Examination of ears and hearing

7.0

307.7

2905

3029

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

18052

83982

N05BA04

ATC

oxazepam; oral

1.9

307.7

6243

24382

P01AB01

ATC

metronidazole; oral, rectal

2.1

307.7

11409

45110

L17

ICPC

Foot/toe symptom/complaint

1.9

307.7

7148

27788

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

3.2

307.7

10421

28551

M03BX02

ATC

tizanidine; oral

1.7

307.7

16204

81570

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.5

307.7

2375

6536

N06AB04

ATC

citalopram; systemic

2.0

307.7

5046

18126

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

3.2

307.7

2801

6293

SPAT1216

SPAT

Assessment of functional ability

2.3

307.7

3284

10110

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

9144

40579

Z04.3

ICD-10 Finland

Examination and observation following other accident

119.5

307.7

875

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.8

307.7

1262

1804

N02AX02

ATC

tramadol; systemic, rectal

2.3

307.7

11664

44236

S52.5

ICD-10 Finland

Fracture of lower end of radius

3.1

307.7

3530

8187

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

21.9

307.7

1713

550

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.3

307.7

3329

10197

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

14626

69399

N81.5

ICD-10 Finland

Vaginal enterocele

8.9

307.7

801

608

WX320

NOMESCO Finland

Spinalanesthesy

2.2

307.7

6968

24687

J01DA01

ATC

[U] cefalexin

1.7

307.7

16037

82357

Z3231

NOMESCO Finland

Registered nurse

2.2

307.7

7210

24800

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

307.7

19283

101662

Z01.8

ICD-10 Finland

Other specified special examinations

8.0

307.7

5258

5221

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.8

307.7

3571

9253

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.7

307.7

2340

6059

LGA22

NOMESCO Finland

Hysteroscopic sterilisation

25.0

307.7

856

233

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.3

307.7

2140

4553

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

13.2

307.7

3511

1989

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

6204

24854

R4110

NOMESCO Finland

Physiotherapy

1.9

307.7

7378

29230

M25.5

ICD-10 Finland

Pain in joint

2.1

307.7

8615

32563

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

3.3

307.7

4668

10620

LCA06

NOMESCO Finland

Biopsy of endometrium

2.3

307.7

3196

10015

N05CF01

ATC

zopiclone; oral

1.8

307.7

7397

31110

N81.6

ICD-10 Finland

Rectocele

5.3

307.7

2759

3754

B01AB05

ATC

enoxaparin; parenteral

2.2

307.7

8672

31185

WX002

NOMESCO Finland

Sedation and analgesia

2.0

307.7

4721

16970

N06AX11

ATC

mirtazapine; oral

1.9

307.7

8506

34059

Z2221

NOMESCO Finland

Medical doctor

1.8

307.7

7560

30978

B02AA02

ATC

tranexamic acid; systemic

2.1

307.7

4140

13894

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

307.7

4461

16020

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

307.7

2515

7058

L08

ICPC

Shoulder symptom/complaint

2.0

307.7

5275

19459

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

307.7

7390

25304

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

307.7

7034

22258

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

11.8

307.7

948

547

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

307.7

5408

17777

N06AX21

ATC

duloxetine; oral

2.7

307.7

2989

7874

Z3226

NOMESCO Finland

Physiotherapist

2.1

307.7

4767

16593

L03

ICPC

Low back symptom/complaint

2.0

307.7

7220

26863

M79.6

ICD-10 Finland

Pain in limb

2.1

307.7

11368

45497

H02AB06

ATC

prednisolone; systemic

1.8

307.7

11437

52175

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

307.7

3186

9402

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

13859

67869

A02BC05

ATC

esomeprazole; systemic

1.9

307.7

10184

42784

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

35.6

307.7

367

N03AX12

ATC

[U] gabapentin; oral

2.5

307.7

3824

11177

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

17.5

307.7

1347

532

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.5

307.7

3242

9101

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.0

307.7

1223

2090

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

10632

47154

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

307.7

6293

23234

N30.0

ICD-10 Finland

Acute cystitis

2.1

307.7

4267

14824

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1774.4

307.7

13372

M01AB05

ATC

diclofenac; systemic, rectal

1.7

307.7

17099

89987

Z00.0

ICD-10 Finland

General medical examination

2.8

307.7

4130

10740

J01CA08

ATC

pivmecillinam; oral

1.9

307.7

11600

50219

L76

ICPC

Fracture: other

4.8

307.7

953

1360

R53

ICD-10 Finland

Malaise and fatigue

1.9

307.7

5945

22711

N81.1

ICD-10 Finland

Cystocele

5.2

307.7

2798

3897

LCD00

NOMESCO Finland

Hysterectomy

3.8

307.7

1489

2676

DFF00

NOMESCO Finland

Pure tone audiometry

3.5

307.7

1836

3601

UJF30

NOMESCO Finland

Ileoscopy through colon

3.2

307.7

2485

5542

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.8

307.7

9860

29693

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

307.7

12165

57409

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

307.7

3052

9164

M54.5

ICD-10 Finland

Low back pain

2.0

307.7

9469

37824

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

307.7

5693

19478

ZXA00

NOMESCO Finland

Right side

1.9

307.7

6451

24986

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

20.9

307.7

1322

438

XQ800

NOMESCO Finland

Prick test

4.3

307.7

1684

2703

ZXD05

NOMESCO Finland

Urgent procedure

2.1

307.7

8977

33923

AA1AD

NOMESCO Finland

CT of head and brain

1.9

307.7

5940

23469

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

4434

14744

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

307.7

9567

40772

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

642.1

307.7

5906

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

307.7

6783

26149

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

10516

47445

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

34.0

307.7

2271

480

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

307.7

11834

50465

XQ802

NOMESCO Finland

Epicutan test

5.8

307.7

848

997

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

2.9

307.7

3006

7485

J01EA01

ATC

trimethoprim; systemic

1.9

307.7

6865

26448

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

307.7

3024

8820

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.1

307.7

2536

5687

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.1

307.7

12190

49270

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

307.7

10467

43346

A04

ICPC

Weakness/tiredness general

2.2

307.7

3584

11827

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

307.7

10664

37164

XA402

NOMESCO Finland

ENMG

12.0

307.7

695

391

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

177.1

307.7

8859

482

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

48.5

307.7

997

141

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

9.6

307.7

5610

4714

J01DB01

ATC

cefalexin; oral

2.2

307.7

22760

122522

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.9

307.7

3165

7836

J02AC01

ATC

fluconazole; systemic

2.0

307.7

10952

45810

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

20.6

307.7

621

204

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

307.7

7701

31729

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

307.7

6359

23740

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

3.9

307.7

1828

3267

N06AX16

ATC

venlafaxine; oral

2.2

307.7

3457

10926

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.0

307.7

1078

1819

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

6.0

307.7

1574

1834

R06.0

ICD-10 Finland

Dyspnoea

1.9

307.7

5878

22596

L28

ICPC

Limited function/disability (L)

2.5

307.7

4427

12873

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

307.7

7674

20513

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

7.9

307.7

1054

916

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

19246

101520

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

4.7

307.7

1831

2714

ZXA05

NOMESCO Finland

Left side

1.9

307.7

6001

23092

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

7519

31760

UJF32

NOMESCO Finland

Coloscopy

2.7

307.7

6597

18944

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

307.7

2431

6529

S82.6

ICD-10 Finland

Fracture of lateral malleolus

3.2

307.7

2019

4384

N03AX16

ATC

[U] pregabalin

2.5

307.7

6104

18493

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

305.1

5830

23314

R32

ICD-10 Finland

Unspecified urinary incontinence

4.7

304.8

836

1206

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.9

301.9

1652

3896

SFA10

NOMESCO Finland

One-surface restoration

1.6

299.7

14102

71696

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.8

299.2

1802

4483

UKC02

NOMESCO Finland

Cystoscopy

2.1

296.8

3325

11025

KMAK, ,

NOMESCO Finland

1.6

295.3

13041

65206

N06AB10

ATC

escitalopram; oral

1.9

294.0

5136

19938

G44.2

ICD-10 Finland

Tension-type headache

2.1

292.8

3339

11145

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

292.8

1369

2937

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

6.3

291.8

594

637

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

290.4

5075

19695

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

289.9

2974

9512

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

289.9

5630

22581

M01AE01

ATC

ibuprofen; systemic, rectal

2.0

288.7

24700

146014

M79.1

ICD-10 Finland

Myalgia

2.1

288.6

3534

12118

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

288.4

3045

9854

ZX120

NOMESCO Finland

Intravenous

2.5

287.3

2096

5753

O02.1

ICD-10 Finland

Missed abortion

2.9

286.9

1581

3741

A28

ICPC

Limited function/disability NOS

2.1

286.8

3536

12154

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

4.1

285.6

934

1559

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

283.8

12928

64899

ULC02

NOMESCO Finland

Hysteroscopy

3.0

283.2

1440

3251

A01

ICPC

Pain general/multiple sites

2.5

282.8

2118

5886

A29

ICPC

General symptom/complaint other

2.2

281.9

2896

9263

L12

ICPC

Hand/finger symptom/complaint

2.0

281.5

4040

14663

XF402

NOMESCO Finland

ECG with work load test

2.5

280.8

2115

5893

L16

ICPC

Ankle symptom/complaint

2.2

280.2

2876

9194

L11

ICPC

Wrist symptom/complaint

2.4

280.1

2395

7079

SFA20

NOMESCO Finland

Two-surface restoration

1.6

279.8

15005

78160

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

279.4

4698

17982

DFF15

NOMESCO Finland

Speech audiometry

4.8

278.6

752

1069

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

3.9

275.1

961

1687

LCH11

NOMESCO Finland

Pharmacologic abortion

3.2

274.3

1264

2685

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

273.0

4449

16843

N80.0

ICD-10 Finland

Endometriosis of uterus

4.6

272.7

768

1133

R06AE07

ATC

cetirizine; oral

1.6

271.1

11028

53707

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

4.0

270.5

902

1528

K02.1

ICD-10 Finland

Caries of dentine

1.6

269.0

15223

79966

L01

ICPC

Neck symptom/complaint

2.0

268.5

3699

13216

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

3.0

267.5

1370

3104

R05

ICPC

Cough

1.8

267.3

5703

23453

LEG12

NOMESCO Finland

Transobturatoric tape

6.0

266.9

567

637

A02BC03

ATC

lansoprazole; oral

1.7

266.0

6238

26354

ZXE00

NOMESCO Finland

One hour or less

1.6

265.5

10363

49907

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

2.3

264.9

2334

6984

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

263.7

3224

11023

LCA16

NOMESCO Finland

Destruction of endometrium

6.9

262.8

494

483

G04BD12

ATC

mirabegron; oral

2.2

262.4

2581

8096

J01MA12

ATC

levofloxacin; systemic

1.9

261.5

4119

15400

U02

ICPC

Urinary frequency/urgency

2.0

259.0

3324

11567

R52.9

ICD-10 Finland

Pain, unspecified

2.3

257.6

2332

7059

LEF53

NOMESCO Finland

Vaginal colpopexy after previous hysterectomy

13.2

257.0

315

160

R5110, ,

SPAT

2.8

256.6

1522

3748

R01AD09

ATC

mometasone; nasal

1.6

256.3

11270

55670

XCK10

NOMESCO Finland

Photography of fundus of eye

2.6

253.5

1696

4450

D01

ICPC

Abdominal pain/cramps general

2.1

252.5

2875

9558

Z97.4

ICD-10 Finland

Presence of external hearing-aid

4.6

252.1

703

1028

LEF51

NOMESCO Finland

Laparoscopic colpopexy after previous hysterectomy

15.8

251.1

283

120

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.6

249.9

1752

4706

M79.7

ICD-10 Finland

Fibromyalgia

4.0

248.8

842

1442

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

247.6

8593

40067

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.5

247.4

995

1931

K30

ICD-10 Finland

Functional dyspepsia

2.2

245.8

2593

8360

J01CA04

ATC

amoxicillin; systemic

1.7

244.8

21831

126023

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

244.8

2482

7874

S06.0

ICD-10 Finland

Concussion

2.2

240.8

2533

8154

C07AB07

ATC

bisoprolol; oral

1.6

240.7

10232

49946

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

239.8

10279

50259

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

239.3

13100

67590

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.3

239.2

2229

6823

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

239.2

2947

10084

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

239.0

9669

46646

N06AA09

ATC

amitriptyline; systemic

2.4

237.4

1988

5805

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

237.0

1861

5276

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

236.9

3191

11276

R2110

NOMESCO Finland

Giving the first information

2.4

236.3

1933

5584

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

4.4

235.9

694

1062

H02AB04

ATC

methylprednisolone; systemic

2.0

235.6

3219

11431

XG410

NOMESCO Finland

Flow-volume spirometry

4.0

235.4

781

1317

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.5

234.5

1700

4638

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

4.0

234.3

790

1349

N02AA05

ATC

oxycodone; systemic

1.9

230.5

3547

13114

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

229.3

1483

3819

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

228.9

2220

6906

R01AD08

ATC

fluticasone; nasal

1.6

228.9

6881

30855

D11

ICPC

Diarrhoea

2.0

227.0

2910

10092

SFA30

NOMESCO Finland

Three-surface restoration

1.5

225.9

10022

49198

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

225.4

6968

31441

R60.0

ICD-10 Finland

Localized oedema

2.1

225.2

2659

8944

WX290

NOMESCO Finland

Other blockage of nerve

1.5

224.4

11879

60557

-1, ,

NOMESCO Finland

1.6

224.2

7927

36939

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

222.1

8424

39884

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

221.9

1336

3312

R15

ICD-10 Finland

Faecal incontinence

4.2

221.7

698

1129

R07.3

ICD-10 Finland

Other chest pain

2.2

220.9

2203

6930

S29

ICPC

Skin symptom/complaint other

1.8

219.6

4284

17047

L74

ICPC

Fracture: hand/foot bone

4.3

218.7

662

1037

XKC03

NOMESCO Finland

Water cystometry

3.8

218.4

777

1381

N02BF02

ATC

pregabalin; oral

2.7

218.4

1336

3340

J01FA10

ATC

azithromycin; systemic

1.5

217.6

14686

78553

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

3.1

216.2

1057

2325

A99

ICPC

Disease/condition unspecnature/site

2.2

215.3

2204

7004

G01AA10

ATC

clindamycin; vaginal

1.8

213.9

3638

13870

C07AA05

ATC

propranolol; systemic

1.7

213.8

4683

19258

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

213.5

1802

5273

N03AX09

ATC

lamotrigine; oral

3.1

211.5

1038

2288

W10

ICD-10 Finland

Fall on and from stairs and steps

2.7

210.9

1346

3440

XKD03

NOMESCO Finland

Urethral pressure profilometry

4.2

210.8

656

1051

H03AA01

ATC

levothyroxine sodium; systemic

1.7

210.3

5339

22847

XF404

NOMESCO Finland

Ambulatory ECG

2.4

209.9

1706

4907

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

2.5

209.4

1557

4295

JGC01

NOMESCO Finland

Laparoscopic rectopexy

9.6

208.2

306

214

O20.0

ICD-10 Finland

Threatened abortion

3.9

207.6

715

1240

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.2

207.1

500

640

G04BD08

ATC

solifenacin; oral

2.6

207.0

1435

3825

R4110, ,

SPAT

2.3

206.7

1920

5857

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

206.6

2344

7754

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.7

206.0

748

1349

R05

ICD-10 Finland

Cough

1.7

205.3

4747

19793

LEG96

NOMESCO Finland

Other vaginal operation for incontinence

24.3

204.7

197

R52.2

ICD-10 Finland

Other chronic pain

3.6

204.2

799

1520

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

204.0

1684

4876

NH1AD

NOMESCO Finland

Ankle and foot CT

4.1

202.1

656

1087

LCA10

NOMESCO Finland

Curettage of body of uterus

3.8

202.0

718

1275

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.7

201.8

752

1382

N05CF02

ATC

zolpidem; oral

1.8

201.2

3893

15418

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.8

201.2

1133

2705

XG405

NOMESCO Finland

Education on PEF monitoring

7.7

200.9

344

299

A02BA02

ATC

ranitidine; systemic

1.8

200.6

3923

15585

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

200.4

4491

18551

R74

ICPC

Upper respiratory infection acute

1.5

200.3

8038

38348

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

200.1

1112

2635

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.1

199.2

969

2124

M01AX17

ATC

nimesulide; oral

1.7

199.0

5094

21806

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

198.7

1758

5248

R02

ICPC

Shortness of breath/dyspnoea

2.0

198.5

2694

9512

Y96.9

ICD-10 Finland

Unspecified type of accident

5.1

198.3

495

654

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

197.5

1878

5782

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

197.1

1758

5266

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

197.1

1105

2631

N80.1

ICD-10 Finland

Endometriosis of ovary

3.3

196.9

865

1778

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

196.6

1112

2661

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

196.6

748

1395

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.7

195.6

1253

3206

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.4

195.2

829

1667

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

3.7

195.1

706

1270

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

194.7

2228

7387

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.6

193.9

1331

3528

R03DC03

ATC

montelukast; oral

1.8

193.5

3675

14461

M01AC06

ATC

meloxicam; systemic, rectal

1.5

193.3

8088

38877

P03

ICPC

Feeling depressed

2.0

191.6

2377

8122

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

191.0

1620

4745

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

190.6

1463

4093

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.4

190.4

1585

4604

G03DC02

ATC

norethisterone; oral

2.0

190.2

2420

8344

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

189.7

3277

12521

LEF54

NOMESCO Finland

Repair of apical defect with mesh

30.8

189.4

171

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

26.3

189.3

178

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

5.0

189.3

479

641

D06

ICPC

Abdominal pain localized other

2.1

189.2

2045

6629

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.9

189.1

1019

2372

L29

ICPC

Musculoskeletal sympt/complt other

2.2

188.5

1931

6127

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.3

188.5

821

1678

H02AB07

ATC

prednisone; oral

1.9

188.3

3006

11199

WX704

NOMESCO Finland

Intubation

2.2

188.3

1871

5864

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

188.1

6442

29573

ULA02

NOMESCO Finland

Kolposcopy

2.0

187.9

2435

8449

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

187.2

3000

11190

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

187.0

998

2310

E0000UV, ,

ATC

1.5

186.7

9720

48821

M48.0

ICD-10 Finland

Spinal stenosis

2.0

186.6

2349

8065

WX702

NOMESCO Finland

Supraglottic ventilation device

2.4

186.2

1415

3940

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.3

186.0

377

402

TND33

NOMESCO Finland

Custom moulded brace or cast, wrist or hand

5.5

184.8

422

511

C03CA01

ATC

furosemide; systemic

1.6

184.8

5629

25118

N02BF01

ATC

gabapentin; oral

2.3

183.5

1684

5103

LEF06

NOMESCO Finland

Anterior colporraphy with mesh for recurrent cystocele

36.5

183.1

159

U71

ICPC

Cystitis/urinary infection other

2.3

183.0

1599

4743

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

182.6

1328

3620

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

182.5

2950

11029

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.4

182.0

529

801

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

181.5

1472

4223

J01FA06

ATC

roxithromycin; oral

1.5

181.4

9153

45616

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

16.4

181.0

200

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

180.8

6287

28922

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

3.2

180.2

830

1758

SPAT1263

SPAT

Sampling

1.5

180.1

9700

48956

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.0

179.6

2422

8518

UJD02

NOMESCO Finland

Gastroscopy

2.9

179.3

989

2332

SPAT1229

SPAT

Assessment of need for aid

2.3

178.7

1494

4345

N05BA01

ATC

diazepam; systemic, rectal

1.9

178.2

2687

9816

H01

ICPC

Ear pain/earache

1.9

177.7

2710

9937

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

176.6

2549

9174

R03BA05

ATC

fluticasone; inhalant

1.7

175.8

4115

17142

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

7.6

175.6

302

264

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.4

175.4

714

1395

A02BC01

ATC

omeprazole; systemic

1.6

175.2

5967

27288

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

174.8

3332

13095

SPAT1254

SPAT

Administration of medicine

1.8

173.4

3084

11868

N83.1

ICD-10 Finland

Corpus luteum cyst

5.5

173.1

395

478

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

172.7

2798

10457

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

172.5

1647

5072

ZY010

NOMESCO Finland

Hospital outpatient

2.7

171.7

1086

2758

Z54.0

ICD-10 Finland

Convalescence following surgery

4.3

171.6

513

795

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

171.6

1627

4995

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

171.5

2119

7217

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.3

171.4

1575

4772

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

171.1

12692

67861

R20.2

ICD-10 Finland

Paraesthesia of skin

2.3

170.9

1547

4657

D02

ICPC

Abdominal pain epigastric

2.4

170.7

1368

3901

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

6.7

170.6

326

325

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.7

170.0

1042

2603

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.3

169.8

1466

4323

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

169.6

3673

14966

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

168.6

3578

14493

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

9.9

168.6

242

163

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

168.2

3327

13207

R13

ICD-10 Finland

Dysphagia

2.4

168.2

1319

3723

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.8

167.7

946

2258

N76.0

ICD-10 Finland

Acute vaginitis

2.2

167.7

1584

4855

R11

ICD-10 Finland

Nausea and vomiting

2.1

167.2

1823

5921

J01FA09

ATC

clarithromycin; systemic

1.5

167.1

7351

35487

A02BC04

ATC

rabeprazole; oral

2.1

166.5

1858

6088

N80.9

ICD-10 Finland

Endometriosis, unspecified

4.0

166.1

551

928

N06AB06

ATC

sertraline; oral

1.9

165.3

2449

8883

SDA03

NOMESCO Finland

Periodontal treatment

1.5

165.3

9642

49204

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.6

165.2

5085

22668

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.9

165.0

897

2097

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

164.9

1073

2765

Z47.8

ICD-10 Finland

Other specified orthopaedic follow-up care

9.0

164.4

251

186

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

163.9

12818

68993

N17

ICPC

Vertigo/dizziness

1.9

163.8

2505

9181

M02AA07

ATC

piroxicam; topical

1.5

163.7

7840

38478

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

163.7

1988

6724

LEF96

NOMESCO Finland

Other operation for prolapse of uterus or vaginal vault

17.3

163.6

177

TLC02

NOMESCO Finland

Simple extraction of IUD

2.6

162.6

1080

2812

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

162.5

1629

5115

R21

ICPC

Throat symptom/complaint

1.6

162.3

5174

23244

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

162.2

1794

5857

L14

ICPC

Leg/thigh symptom/complaint

2.1

162.2

1716

5506

XCK00

NOMESCO Finland

Perimetry

2.7

161.7

1035

2644

R96

ICPC

Asthma

2.0

161.2

1958

6622

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

160.8

2684

10115

Z2446

NOMESCO Finland

Social worker

2.3

160.5

1415

4209

NCJ62

NOMESCO Finland

Internal fixation of fracture of forearm using plate

3.5

159.4

634

1219

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.0

159.3

1956

6640

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

158.8

1155

3145

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

158.1

5216

23603

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.9

157.7

2427

8908

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.9

157.6

2376

8662

S80.0

ICD-10 Finland

Contusion of knee

2.1

157.5

1750

5721

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

157.1

2389

8734

P01

ICPC

Feeling anxious/nervous/tense

1.8

157.0

2873

11132

U01

ICPC

Dysuria/painful urination

2.1

157.0

1783

5879

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

156.9

5267

23921

A98

ICPC

Health maint/preventive medicine

2.1

156.8

26704

167399

JG1JB

NOMESCO Finland

Defekography with X-ray

8.2

156.7

255

207

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

2.0

156.6

1947

6639

O02.0

ICD-10 Finland

Blighted ovum and nonhydatidiform mole

3.0

155.9

808

1837

M05BA04

ATC

alendronic acid; oral

2.1

155.7

1720

5610

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

155.6

2180

7752

N06AB03

ATC

fluoxetine; oral

1.8

155.5

2566

9629

L72

ICPC

Fracture: radius/ulna

3.9

155.4

529

909

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

154.7

4774

21255

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

6.4

154.1

306

319

A03

ICPC

Fever

1.6

153.8

3962

16872

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

153.7

1313

3850

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

153.6

1801

6009

M01AH01

ATC

celecoxib; oral

1.7

153.4

3698

15478

XCH00

NOMESCO Finland

Eye pressure measurement

3.0

153.3

780

1754

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.5

153.3

610

1173

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

153.1

1541

4844

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.9

152.9

815

1883

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

152.6

1465

4516

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

152.6

2007

6981

Z01.9

ICD-10 Finland

Special examination, unspecified

2.5

152.4

1094

2959

MBA96

NOMESCO Finland

Other removal of retained products of conception after delivery or abortion

3.6

152.4

573

1059

M01AH02

ATC

rofecoxib; oral

1.8

152.1

2586

9792

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

152.0

3514

14542

R4120

NOMESCO Finland

Occupational therapy

2.2

151.3

1515

4752

G03DB01

ATC

dydrogesterone; oral

1.7

151.2

3038

12091

M01AX05

ATC

glucosamine; oral

1.7

151.0

3773

15934

MBA03

NOMESCO Finland

Curettage of uterus after delivery or abortion

3.0

150.8

778

1764

R06AX22

ATC

ebastine; oral

1.6

150.4

3857

16397

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.9

150.1

515

890

N05BA12

ATC

alprazolam; oral

1.9

149.4

2047

7220

A06AD11

ATC

lactulose; oral

1.8

149.1

2777

10807

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

2.7

148.7

901

2235

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

147.6

2343

8678

K59.01

ICD-10 Finland

Constipation outlet obstruction type

5.8

147.5

321

370

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

147.3

3540

14790

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

147.2

5337

24616

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

3.3

147.1

626

1259

LEF40

NOMESCO Finland

Vaginal repair of enterocele

9.4

146.3

217

154

SPAT1153

SPAT

Removal of sutures

1.5

146.0

6422

30848

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.0

145.7

370

497

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.3

145.5

1290

3843

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.0

145.1

473

786

T78.4

ICD-10 Finland

Allergy, unspecified

2.6

144.9

983

2585

L86

ICPC

Back syndrome with radiating pain

2.3

144.6

1298

3888

R35

ICD-10 Finland

Polyuria

2.3

144.3

1261

3733

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.1

144.1

460

752

R00.2

ICD-10 Finland

Palpitations

2.1

143.5

1642

5424

ACC51

NOMESCO Finland

Release of median nerve

2.1

143.2

1601

5242

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.8

143.1

504

888

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.2

143.1

653

1374

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

142.9

8137

41058

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

142.8

4740

21417

MBA00

NOMESCO Finland

Vacuum aspiration from uterus after delivery or abortion

3.4

142.6

597

1188

N03AE01

ATC

clonazepam; systemic

2.4

142.0

1090

3043

S62.6

ICD-10 Finland

Fracture of other finger

2.4

141.9

1104

3102

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

4.2

141.7

444

715

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

141.2

2819

11186

R06AX27

ATC

desloratadine; oral

1.5

140.6

6647

32350

W17

ICD-10 Finland

Other fall from one level to another

2.4

140.4

1058

2928

M54.2

ICD-10 Finland

Cervicalgia

2.1

140.3

1637

5446

D07AC01

ATC

betamethasone; topical

1.4

139.5

7894

39751

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

2.9

138.9

734

1687

NG2AA

NOMESCO Finland

Patella X-ray examination

3.2

138.9

636

1341

SPAT1211

SPAT

Application of soft bandage

1.9

138.7

1881

6606

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

7.8

138.5

234

200

N01

ICPC

Headache

1.8

138.4

2566

9960

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

5.5

138.1

315

381

P76

ICPC

Depressive disorder

2.1

137.9

1426

4527

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

4.9

137.8

358

491

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

137.2

4486

20181

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

136.8

2195

8150

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

136.3

2670

10530

G04BD04

ATC

oxybutynin; oral, transdermal

2.4

136.0

1097

3133

UJH02

NOMESCO Finland

Anoscopy

2.6

135.9

871

2225

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

135.9

2567

10018

Z09.1

ICD-10 Finland

Follow-up examination after radiotherapy for other conditions

268.5

135.8

162

XA420

NOMESCO Finland

Extensive sleep examination

7.5

135.4

235

208

P20

ICPC

Memory disturbance

1.8

135.1

2287

8633

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

134.7

1079

3071

SPAT1240

SPAT

Therapeutic discussion

1.8

133.8

2301

8728

L02

ICPC

Back symptom/complaint

1.8

133.7

2217

8314

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

3.6

133.4

511

957

R01AD58

ATC

fluticasone, combinations; nasal

1.5

133.3

5601

26578

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

133.3

2419

9326

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

132.9

1457

4731

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

132.5

2274

8618

R50.9

ICD-10 Finland

Fever, unspecified

1.7

132.4

2987

12247

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

132.3

5648

26881

EBA00

NOMESCO Finland

Extraction of tooth

1.4

132.2

8200

41893

K29

ICPC

Cardiovascular sympt/complt other

2.7

132.1

832

2106

D19

ICPC

Teeth/gum symptom/complaint

1.5

131.4

6477

31708

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.9

131.2

697

1607

R29

ICPC

Respiratory symptom/complaint other

2.1

130.9

1378

4404

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

4.8

130.8

347

485

J01MA06

ATC

norfloxacin; oral

1.7

130.8

2883

11745

Y60

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

5.7

130.5

286

332

S97

ICPC

Chronic ulcer skin

2.3

130.3

1145

3396

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

130.1

5396

25519

N81.3

ICD-10 Finland

Complete uterovaginal prolapse

6.1

129.9

269

294

J05AB01

ATC

aciclovir; systemic

1.5

129.8

4723

21728

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

129.7

1120

3296

SPAT1104

SPAT

Monitoring of emergency patient

2.2

129.7

1307

4105

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

129.6

17226

99579

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

129.6

1411

4569

C05AA08

ATC

fluocortolone; rectal, topical

1.7

129.3

2806

11380

G47.3

ICD-10 Finland

Sleep apnoea

1.6

129.3

4273

19242

C01CA24

ATC

epinephrine; parenteral

2.2

129.3

1271

3952

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.6

129.3

887

2345

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

128.8

2046

7566

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

128.7

3964

17561

A06AC51

ATC

ispaghula, combinations; oral

2.4

128.7

1000

2806

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

128.1

890

2367

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

127.9

2419

9435

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.4

127.7

1031

2944

A77

ICPC

Viral disease other/NOS

2.5

127.2

936

2560

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.4

127.0

971

2704

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.2

127.0

1196

3653

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

126.6

1214

3735

K07.60

ICD-10 Finland

Snapping jaw

2.3

126.0

1122

3346

E66.8

ICD-10 Finland

Other obesity

2.2

125.7

1184

3616

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

125.7

8004

40998

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

125.4

866

2296

R03BA02

ATC

budesonide; inhalant

1.6

125.3

3793

16728

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

125.1

1477

4930

D07AD01

ATC

clobetasol; topical

1.6

125.0

3462

14946

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.5

124.5

923

2533

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

124.3

2401

9418

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

124.0

683

1607

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

123.7

1663

5815

G04BD07

ATC

tolterodine; oral

2.4

123.6

973

2747

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

3.3

123.5

534

1085

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

2.0

123.5

1616

5598

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

123.4

4391

20077

Z09.7

ICD-10 Finland

Follow-up examination after combined treatment for other conditions

167.6

123.4

151

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.8

123.4

2207

8463

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

123.3

1988

7383

C09CA06

ATC

candesartan; oral

1.5

123.3

4994

23470

N06AX12

ATC

bupropion; oral

2.0

123.2

1493

5032

A10AB05

ATC

insulin aspart; parenteral

2.1

123.0

1296

4142

U07

ICPC

Urine symptom/complaint other

2.0

122.9

1499

5064

R01AD12

ATC

fluticasone furoate; nasal

1.4

122.9

7323

37045

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

122.6

697

1669

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.7

122.6

775

1965

SFA00

NOMESCO Finland

Small restoration

1.7

122.1

2924

12165

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

122.0

1521

5178

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

121.8

1304

4193

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.5

121.8

477

907

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.8

121.7

700

1687

S82.3

ICD-10 Finland

Fracture of lower end of tibia

3.3

121.3

535

1101

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.7

121.1

436

781

WX402

NOMESCO Finland

General anaesthesia

1.5

121.0

4955

23326

K08.80

ICD-10 Finland

Toothache NOS

1.8

121.0

1933

7156

EB1VA, ,

NOMESCO Finland

1.7

120.8

2650

10768

S82.1

ICD-10 Finland

Fracture of upper end of tibia

3.4

120.7

490

955

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.1

120.3

565

1210

N03AG01

ATC

valproic acid; systemic, rectal

2.2

120.2

1113

3374

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

4.6

120.2

336

492

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.9

119.9

413

716

J02AC02

ATC

itraconazole; systemic

1.6

119.9

3821

17038

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

119.7

662

1561

C08CA01

ATC

amlodipine; oral

1.4

119.6

7495

38214

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.1

119.5

1250

3983

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

119.5

2028

7651

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

119.3

1980

7417

S82.0

ICD-10 Finland

Fracture of patella

3.6

119.0

449

832

N83.0

ICD-10 Finland

Follicular cyst of ovary

4.0

118.3

390

654

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.2

117.8

533

1115

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

2.3

117.6

988

2871

R55

ICD-10 Finland

Syncope and collapse

1.8

117.5

2066

7877

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

3.6

117.4

454

856

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

117.2

2356

9341

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.9

117.2

609

1386

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

117.0

6626

33162

P29

ICPC

Psychological sympt/compl other

2.0

116.9

1441

4884

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

116.9

2364

9388

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

116.9

5547

26865

UJF92

NOMESCO Finland

Capsular endoscopy

4.0

116.9

388

654

SPAT1252

SPAT

Overall medication plan or its review

2.2

116.6

1072

3239

J01DA09

ATC

[U] cefadroxil

1.4

116.5

5911

28988

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

2.4

116.4

906

2543

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

116.4

737

1870

P06

ICPC

Sleep disturbance

1.7

116.3

2505

10123

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.8

116.2

303

417

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

116.0

1690

6069

T89

ICPC

Diabetes insulin dependent

2.8

115.9

643

1519

H29

ICPC

Ear symptom/complaint other

1.7

115.6

2244

8807

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

115.2

2918

12303

D07AC13

ATC

mometasone; topical

1.4

115.2

6272

31153

G01AF05

ATC

econazole; vaginal

1.9

115.0

1707

6168

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.9

114.9

600

1369

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

114.9

2820

11795

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

114.5

4744

22358

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

6.2

114.4

233

250

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

114.4

8964

47358

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.9

114.1

619

1444

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.9

114.0

1616

5750

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

113.5

2277

9019

WX722

NOMESCO Finland

PEEP

2.4

113.3

862

2394

G01AF01

ATC

metronidazole; vaginal

1.8

113.1

2027

7769

R83

ICPC

Respiratory infection other

1.4

112.9

6055

29973

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

112.8

2051

7895

R19.5

ICD-10 Finland

Other faecal abnormalities

4.1

112.7

360

589

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

112.6

1663

5998

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

112.2

1290

4261

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

3.1

111.7

530

1142

R12

ICD-10 Finland

Heartburn

1.9

111.7

1678

6086

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.4

111.6

464

919

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.0

111.3

559

1247

S82.7

ICD-10 Finland

Multiple fractures of lower leg

4.5

111.2

318

475

RD211, ,

NOMESCO Finland

2.9

111.2

593

1370

S22.3

ICD-10 Finland

Fracture of rib

2.0

111.2

1375

4665

ND1AD

NOMESCO Finland

Wrist CT examination

4.5

110.9

314

465

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.9

110.9

1727

6337

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

2.1

110.8

1151

3655

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

110.7

4481

21002

M02AA10

ATC

ketoprofen; topical

1.6

110.7

3223

14052

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

110.6

1874

7060

SPAT1301

SPAT

No procedures

1.4

110.5

6501

32695

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

110.3

6243

31184

O00.1

ICD-10 Finland

Tubal pregnancy

3.5

110.1

429

813

Z2445

NOMESCO Finland

Psychologist

2.6

109.9

746

1961

A07AA02

ATC

nystatin; oral

2.2

109.8

1069

3307

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

109.5

1495

5250

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.6

109.5

746

1964

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

109.5

1303

4358

A11

ICPC

Chest pain NOS

1.9

109.5

1493

5241

S42.0

ICD-10 Finland

Fracture of clavicle

2.7

109.5

692

1754

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

2.9

109.4

586

1357

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.6

109.3

2715

11383

LWW96

NOMESCO Finland

Other reoperation in gynaecological surgery

14.1

109.0

129

A10AE04

ATC

insulin glargine; parenteral

1.9

109.0

1591

5715

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.5

108.7

433

833

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

108.7

1195

3880

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

108.5

2171

8589

L09

ICPC

Arm symptom/complaint

2.2

108.2

1014

3088

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

108.0

890

2564

A08

ICPC

Swelling

2.3

107.7

956

2845

Z01.7

ICD-10 Finland

Laboratory examination

1.6

107.6

2853

12154

K59.0

ICD-10 Finland

Constipation

2.1

107.6

1090

3427

H25.8

ICD-10 Finland

Other senile cataract

1.8

107.4

1836

6933

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

2.7

107.4

641

1576

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.0

107.4

532

1177

CS494

NOMESCO Finland

Other visual field testing

3.6

107.2

405

751

G04BD09

ATC

trospium; oral

3.1

107.2

510

1101

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

106.9

4574

21661

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.7

106.8

644

1592

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

3.6

106.7

402

744

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

106.7

649

1612

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

4.1

106.7

343

564

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.9

106.4

578

1349

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.1

106.3

1143

3679

G03DC03

ATC

lynestrenol; oral

3.0

106.2

548

1242

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.5

106.1

760

2051

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

2.7

106.0

657

1648

U04

ICPC

Incontinence urine

2.2

105.8

979

2965

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

105.8

670

1700

O03.4

ICD-10 Finland

Spontaneous abortion, Incomplete, without complication

3.0

105.8

548

1245

Z47.0

ICD-10 Finland

Follow-up care involving removal of fracture plate and other internal fixation device

6.6

105.1

202

203

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.0

104.9

1293

4380

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

12.0

104.8

134

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

104.5

8758

46592

ZXA10

NOMESCO Finland

Bilateral

1.5

104.4

3715

16928

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

104.3

1219

4049

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

104.2

1714

6395

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

103.8

6440

32627

TAB00

NOMESCO Finland

Lumbar puncture

2.4

103.4

806

2263

L73

ICPC

Fracture: tibia/fibula

4.1

103.3

329

537

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

103.0

3984

18470

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

5.1

102.5

253

331

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

102.2

2752

11761

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.6

102.0

388

723

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

102.0

505

1117

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

101.9

1203

4011

A01AB09

ATC

miconazole; local oral

1.8

101.8

1716

6449

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

101.5

4433

21055

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

3.6

101.4

382

707

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

3.4

101.3

412

804

-34

ICPC

Blood test

2.8

101.3

577

1383

M01AB55

ATC

diclofenac, combinations; oral

2.0

101.2

1245

4213

M54.3

ICD-10 Finland

Sciatica

2.0

101.1

1179

3912

1412

FHL

Laparoscopy and sterilization

2.0

101.0

1219

4097

L95

ICPC

Osteoporosis

2.6

100.9

662

1710

A03FA02

ATC

cisapride; oral, rectal

1.9

100.9

1409

4984

F29

ICPC

Eye symptom/complaint other

1.7

100.8

1917

7469

S52.0

ICD-10 Finland

Fracture of upper end of ulna

3.2

100.7

461

972

-57

ICPC

Physical medicine/rehabilitation

12.2

100.6

128

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

100.3

4025

18793

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

100.0

4650

22346

R03BA08

ATC

ciclesonide; inhalant

1.8

100.0

1644

6131

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.7

100.0

613

1529

LEF01

NOMESCO Finland

Anterior colporraphy with mesh for primary cystocele

42.9

99.8

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.9

99.5

1535

5610

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.3

99.4

430

874

S76

ICPC

Skin infection other

2.1

99.4

1035

3288

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.9

99.3

546

1283

R51

ICD-10 Finland

Headache

2.0

99.0

1218

4122

M77.1

ICD-10 Finland

Lateral epicondylitis

1.8

99.0

1690

6376

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.6

98.9

275

401

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

98.9

1077

3482

K62.3

ICD-10 Finland

Rectal prolapse

4.1

98.7

316

518

LCA17

NOMESCO Finland

Thermal treatment of endometrium

25.0

98.5

M54.8

ICD-10 Finland

Other dorsalgia

2.2

98.3

921

2803

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.9

98.3

1355

4771

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

98.3

2011

7997

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.8

98.2

1686

6371

Z09.2

ICD-10 Finland

Follow-up examination after chemotherapy for other conditions

+∞

98.0

111

E000001, ,

ATC

1.5

97.9

4214

19943

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.9

97.8

1309

4562

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.7

97.8

2196

8955

WX400

NOMESCO Finland

Inhalation anesthesy

2.2

97.7

912

2772

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

97.6

6224

31624

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

97.5

1102

3613

Y96.8

ICD-10 Finland

Other type of accident

6.1

97.5

202

221

NG1AD

NOMESCO Finland

Knee CT examination

3.6

97.4

365

673

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.2

97.2

886

2666

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.7

97.2

347

618

F34.1

ICD-10 Finland

Dysthymia

2.5

97.1

678

1807

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

7.1

97.0

176

165

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.0

96.6

473

1039

R06AE09

ATC

levocetirizine; oral

1.6

96.6

3056

13551

N81.4

ICD-10 Finland

Uterovaginal prolapse, unspecified

4.4

96.5

282

429

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

10.2

96.5

136

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

96.5

1038

3340

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.9

96.3

501

1141

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

3.6

96.2

371

698

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

96.0

2920

12831

NDJ40

NOMESCO Finland

Closed reduction of fracture of wrist or hand

3.9

95.9

328

566

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.2

95.0

944

2944

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

94.8

1002

3202

N06AX26

ATC

vortioxetine; oral

1.9

94.7

1416

5122

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.1

94.6

1034

3347

L90

ICPC

Osteoarthrosis of knee

1.9

94.4

1254

4358

LEG13

NOMESCO Finland

Vaginal transobturatorial urethropexy

6.0

94.4

199

222

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.0

93.9

477

1071

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

93.9

7353

38567

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

93.9

2440

10325

S21

ICPC

Skin texture symptom/complaint

1.6

93.8

2831

12416

N04BC05

ATC

pramipexole; oral

1.9

93.7

1349

4819

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.1

93.5

294

475

SGA01

NOMESCO Finland

Emergency treatment

1.5

93.5

3532

16266

R51.81

ICD-10 Finland

Facial pain NOS

3.0

93.2

468

1044

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.3

93.0

815

2411

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

92.9

1750

6794

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

92.8

2226

9230

T83.8

ICD-10 Finland

Other complications of genitourinary prosthetic devices, implants and grafts

21.8

92.5

Y94.8

ICD-10 Finland

Other leisure activity accident

2.6

92.4

598

1534

S52.1

ICD-10 Finland

Fracture of upper end of radius

2.9

92.4

491

1132

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

92.3

1547

5800

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

92.2

719

2019

JG1JG

NOMESCO Finland

MRI of rectal function (MR defecography)

9.5

92.2

135

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

3.9

92.2

313

537

SPAT1310

SPAT

Counselling related to known health issue

1.4

92.2

6601

34124

LWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gynaecological surgery

7.6

92.1

158

138

S82.5

ICD-10 Finland

Fracture of medial malleolus

3.6

92.0

347

643

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

91.8

1260

4428

R09

ICPC

Sinus symptom/complaint

1.8

91.8

1710

6617

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

91.7

3927

18543

T74.1

ICD-10 Finland

Physical abuse

3.2

91.6

407

842

O04.1

ICD-10 Finland

Medical abortion, incomplete, complicated by delayed or excessive haemorrhage

4.8

91.5

238

327

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.5

91.5

672

1835

ZXD35

NOMESCO Finland

Usual procedure

2.3

91.3

748

2148

KDG30

NOMESCO Finland

Suprapubic sling urethrocystopexy

11.1

91.3

122

L04

ICPC

Chest symptom/complaint

2.0

91.2

1192

4119

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.6

91.2

600

1552

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

91.1

1746

6810

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.8

91.1

530

1285

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.5

90.8

208

253

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

90.2

953

3044

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

90.1

472

1079

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

90.1

653

1772

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.1

89.7

959

3077

K56.1

ICD-10 Finland

Intussusception

7.1

89.7

162

151

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.5

89.6

3324

15240

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

89.4

2127

8797

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

89.3

1060

3538

NF3AA

NOMESCO Finland

Femur X-ray examination

3.0

89.2

436

957

K03.66

ICD-10 Finland

Tooth plaque

1.8

88.8

1425

5269

A10AB04

ATC

insulin lispro; parenteral

2.9

88.8

481

1121

H92.0

ICD-10 Finland

Otalgia

1.9

88.5

1253

4449

A46

ICD-10 Finland

Erysipelas

1.6

88.3

2606

11359

C10AC01

ATC

colestyramine; oral

2.8

88.2

501

1199

N70.0

ICD-10 Finland

Acute salpingitis and oophoritis

5.2

88.2

213

273

A23

ICPC

Risk factor NOS

1.7

88.2

1852

7410

N03AX11

ATC

topiramate; oral

2.8

88.0

486

1145

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

87.8

875

2731

M77.4

ICD-10 Finland

Metatarsalgia

1.9

87.7

1249

4443

G03DA02

ATC

medroxyprogesterone; systemic

1.7

87.6

1751

6910

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

87.6

790

2366

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

87.5

4639

22771

XG466

NOMESCO Finland

Sleep oxymetry

2.7

87.5

527

1302

U05

ICPC

Urination problems other

2.1

87.3

892

2812

R01AD11

ATC

triamcinolone; nasal

1.7

87.3

1653

6424

A10AE05

ATC

insulin detemir; parenteral

2.2

87.1

849

2626

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.2

87.0

790

2373

P01BA02

ATC

hydroxychloroquine; oral

1.8

86.8

1578

6059

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

86.8

771

2294

M54.1

ICD-10 Finland

Radiculopathy

2.3

86.8

757

2235

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.6

86.7

2104

8744

L10

ICPC

Elbow symptom/complaint

2.0

86.7

1086

3696

R33

ICD-10 Finland

Retention of urine

1.9

86.6

1320

4801

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

86.6

1441

5388

N06AA12

ATC

doxepin; systemic

2.1

86.6

902

2865

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

86.3

966

3154

S82.4

ICD-10 Finland

Fracture of fibula alone

3.1

86.1

415

903

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.3

86.1

764

2272

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.8

85.9

491

1179

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

85.9

738

2164

S92.5

ICD-10 Finland

Fracture of other toe

2.5

85.8

605

1620

C10AA05

ATC

atorvastatin; oral

1.3

85.8

7849

42015

P15

ICPC

Chronic alcohol abuse

2.6

85.7

557

1432

ZXD20

NOMESCO Finland

Day surgery

1.5

85.6

2810

12544

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007164) IgA [Mass/volume] in Serum or Plasma

5912

23474

1.84

318.35

1.5

1.4

2.32

2.36

g/l

0.71

3276

14743

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

22113

125344

1.78

315.66

5.7

4.6

39.18

38.61

mmol/mol

14.40

20752

115885

(3033658) Prothrombin time (PT) actual/Normal

7671

33019

1.74

314.86

4.2

3.3

92.38

91.04

4.68

7510

32238

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9187

41573

1.69

314.44

3.2

2.7

32.34

33.96

u/l

0.63

8796

39244

(3018095) Leukocytes [#/volume] in Urine

9875

45589

1.67

313.08

4.1

3.1

91.56

99.35

e6/l

0.34

6994

29630

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

23515

135929

1.88

312.78

4.5

3.8

5.85

5.78

mmol/l

11.57

21854

124094

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

20279

106981

1.91

307.65

4.4

3.6

14.60

14.63

pmol/l

0.97

18845

96807

(3044640) Blood type and Crossmatch panel - Blood

10207

40958

2.02

307.65

2.4

2.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13691

61929

1.90

307.65

5.8

5.5

10.45

11.62

umol/l

27.44

12994

58419

(3013115) Eosinophils [#/volume] in Blood

13995

63892

1.89

307.65

6.4

5.1

0.19

e9/l

0.59

12409

55022

(3019550) Sodium [Moles/volume] in Serum or Plasma

25186

143431

2.55

307.65

17.3

11.9

139.59

139.67

mmol/l

4.96

24735

138891

(40768797) Stomach Pathology biopsy report

4306

13884

2.24

307.65

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1267

2301

3.77

307.65

2.6

2.1

—

(3006315) Basophils [#/volume] in Blood

13558

61656

1.88

307.65

6.2

5.0

0.04

e9/l

2.30

11833

51902

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6530

25925

1.87

307.65

1.8

1.6

1.14

1.25

mg/l

1.73

4963

19817

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

25119

143218

2.50

307.65

16.0

10.4

21.76

24.30

mg/l

26.35

20705

108522

(3013707) Erythrocyte sedimentation rate by Westergren method

19464

96034

2.11

307.65

4.4

3.3

11.79

11.44

mm/h

2.94

18244

88401

(3013826) Glucose [Moles/volume] in Serum or Plasma

15526

72289

1.94

307.65

4.8

4.0

6.59

mmol/l

0.04

14569

66087

(3031040) Bacteria [#/volume] in Urine by Automated count

17922

88207

1.95

307.65

5.2

3.6

2388.48

1350.52

e6/l

0.92

157

1679

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13539

62785

1.82

307.65

2.7

2.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7044

28180

1.87

307.65

2.4

2.0

2.85

2.88

mg/l

0.58

6051

23819

(40768804) Tissue Pathology biopsy report

11812

53676

1.79

307.65

2.2

1.9

—

(3013512) EKG study

7828

32043

1.85

307.65

3.8

3.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

12572

58331

1.77

307.65

6.4

5.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

11974

52867

1.87

307.65

12.5

12.3

1.19

1.22

inr

2.00

3037

16961

(3006504) Eosinophils/100 leukocytes in Blood

13164

58370

1.93

307.65

6.4

5.1

2.88

2.80

3.65

12321

54444

(3023103) Potassium [Moles/volume] in Serum or Plasma

25249

143985

2.57

307.65

17.5

12.0

3.94

3.95

mmol/l

2.54

24733

139114

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7035

28229

1.87

307.65

3.0

2.6

1331.82

1422.77

ng/l

0.80

5929

23878

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5283

19057

2.03

307.65

3.1

2.5

3.18

3.22

e6/l

0.06

3041

8719

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4229

11821

2.61

307.65

4.4

3.9

32.57

32.23

1.17

3292

8045

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2172

5535

2.73

307.65

1.7

1.5

—

(3019225) pH of Specimen

3480

8421

2.98

307.65

4.4

3.4

—

(3045414) Leukocytes [Presence] in Urine

1861

4230

3.05

307.65

2.0

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5488

20914

1.91

307.65

3.7

3.1

430.38

561.81

ng/l

0.91

3918

15645

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17721

94094

1.67

307.65

3.4

2.5

45.80

43.31

u/l

2.98

16759

88236

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11890

49959

2.00

307.65

2.4

2.0

77.20

76.08

nmol/l

3.88

10822

45166

(40758558) Short blood count panel - Blood

7530

30641

1.85

307.65

6.7

6.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

23878

132778

2.26

307.65

14.3

10.4

84.43

84.29

ml/min/173m2

0.40

20474

105614

(3018010) Neutrophils/100 leukocytes in Blood

13461

60143

1.92

307.65

6.2

5.0

56.77

57.16

3.38

12654

56335

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

12144

52123

1.95

307.65

6.1

5.1

1.22

1.21

mmol/l

26.74

11192

47531

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

19777

98373

2.11

307.65

7.7

6.3

77.12

77.71

u/l

1.09

18727

91905

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25921

154833

2.37

307.65

11.1

8.1

25.46

26.01

u/l

2.89

25230

148827

(3019198) Lymphocytes [#/volume] in Blood

13912

64275

1.86

307.65

6.3

5.0

1.95

1.94

e9/l

0.06

12473

55862

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11466

45746

2.11

307.65

2.1

1.7

97.89

95.41

pmol/l

5.12

6147

23167

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8055

29689

2.11

307.65

2.4

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

13380

56441

2.08

307.65

6.9

5.3

1.22

1.21

mmol/l

13.96

11966

45511

(3020564) Creatinine [Moles/volume] in Serum or Plasma

25887

153530

2.45

307.65

17.6

12.2

73.12

74.47

umol/l

9.31

25878

153450

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12437

59607

1.68

307.65

3.1

2.5

104.75

113.26

ug/l

1.05

11666

55394

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8568

35483

1.86

307.65

2.7

2.2

56.31

66.50

u/l

2.70

7984

32567

(3021960) Folate [Moles/volume] in Serum or Plasma

6481

25331

1.90

307.65

1.6

1.4

20.78

20.11

nmol/l

2.73

5678

21738

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6841

27440

1.86

307.65

1.3

1.2

2.18

1.66

u/ml

1.37

1400

7895

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5378

20360

1.92

307.65

3.0

2.4

0.96

1.42

e6/l

2.15

3124

9979

(3013650) Neutrophils [#/volume] in Blood by Automated count

15190

73276

1.81

307.65

8.8

8.0

4.05

4.13

e9/l

4.32

13228

62303

(3001604) Monocytes [#/volume] in Blood

13526

61544

1.87

307.65

6.2

5.0

0.57

0.58

e9/l

4.45

11801

51865

(3037467) Urinalysis macro (dipstick) panel - Urine

18470

92974

1.92

307.65

4.9

3.5

—

(3022096) Basophils/100 leukocytes in Blood

12746

56478

1.90

307.65

6.4

5.2

0.69

0.66

5.53

11910

52478

(3002030) Lymphocytes/100 leukocytes in Blood

13599

61394

1.90

307.65

6.4

5.1

28.59

28.28

2.56

12780

57577

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23593

130081

2.24

307.65

5.3

4.1

1.87

2.14

mu/l

2.53

22107

119185

(3026008) Bacteria identified in Urine by Culture

8697

37331

1.78

307.65

3.3

2.6

—

(3019069) Monocytes/100 leukocytes in Blood

13220

58759

1.92

307.65

6.7

5.3

8.35

8.48

4.74

12397

54892

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8222

32029

1.99

307.65

2.2

1.9

189.96

211.99

u/l

0.58

7783

29802

(3048689) Calprotectin [Mass/mass] in Stool

3997

14133

2.02

301.38

2.3

2.4

129.60

134.47

ug/g

0.35

3157

11157

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9286

42513

1.66

301.04

3.6

3.0

49.08

55.55

ng/l

0.24

5829

26244

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3787

13156

2.05

299.44

2.6

2.4

6.86

9.03

umol/l

8.43

3306

11226

(3024561) Albumin [Mass/volume] in Serum or Plasma

10738

51220

1.63

294.66

4.7

4.2

35.86

35.63

g/l

4.22

10082

47252

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4529

16899

1.92

292.16

1.9

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

8476

38121

1.67

292.00

3.6

2.7

44.27

107.84

e6/l

8.41

6570

27377

(3022948) Iron [Moles/volume] in Serum or Plasma

4551

17082

1.91

288.06

2.6

2.1

13.12

13.50

umol/l

2.43

4292

15792

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1360

2942

3.16

286.91

3.8

3.1

24.83

24.95

mmol/l

0.68

1280

2704

(3030467) Casts [#/volume] in Urine by Automated count

7819

34914

1.67

273.06

3.5

2.7

0.38

0.47

e6/l

2.84

6032

24750

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4195

15718

1.90

264.87

2.5

2.1

2.37

2.35

g/l

1.44

3923

14343

(3037522) Nuclear Ab [Titer] in Serum

4201

15848

1.89

259.35

1.4

1.3

521.27

546.61

titre

0.35

916

2930

(40761511) CBC panel - Blood by Automated count

25462

153220

2.05

259.08

13.9

10.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4992

19913

1.80

258.10

1.3

1.2

14.14

11.87

u/ml

0.51

1622

8100

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5239

21252

1.78

255.86

1.3

1.2

33.23

35.11

iu/ml

0.15

1668

7027

(3022313) Gas panel - Capillary blood

1448

3484

2.85

254.53

3.8

3.0

—

(3007461) Platelets [#/volume] in Blood

26981

166545

2.76

253.19

23.2

15.2

258.79

254.31

e9/l

24.07

26494

160922

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

9412

44709

1.59

251.98

3.6

2.7

—

0.26

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3918

14583

1.90

251.23

2.6

2.2

22.13

23.27

4.96

3544

12431

(3009542) Hematocrit [Volume Fraction] of Blood

26951

166364

2.72

250.20

23.3

15.3

39.68

40.52

16.03

26047

155557

(3010813) Leukocytes [#/volume] in Blood

26994

166770

2.76

249.94

23.3

15.2

6.74

6.69

e9/l

3.53

26430

160564

(3024731) MCV [Entitic volume]

26990

166748

2.75

249.47

23.2

15.2

90.89

90.57

25.29

26743

164006

(3026361) Erythrocytes [#/volume] in Blood

26990

166770

2.75

248.78

23.2

15.2

4.44

4.52

e12/l

135.73

26434

160612

(3035941) MCH [Entitic mass]

26984

166726

2.74

248.42

23.1

15.2

30.20

0.15

26740

163990

(3000963) Hemoglobin [Mass/volume] in Blood

26992

166844

2.74

247.06

23.4

15.3

133.23

135.77

g/l

176.17

26757

164164

(36304419) Bacteria [Presence] in Urine

7617

34504

1.63

246.60

3.4

2.6

—

(3023368) Bacteria identified in Blood by Culture

6948

30771

1.66

245.59

4.3

4.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2311

7107

2.25

245.56

3.9

3.3

86.58

86.26

ng/l

0.05

2044

6093

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1435

3525

2.78

242.75

2.0

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

22923

134311

1.70

238.11

3.9

3.4

1.29

1.25

mmol/l

9.15

21395

123760

(3000330) Specific gravity of Urine by Test strip

1831

5183

2.43

233.84

3.3

3.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

24137

143940

1.77

226.87

4.8

4.1

2.80

2.84

mmol/l

7.89

22673

133324

(3042936) Bacteria identified in Isolate by Culture

4052

15730

1.82

225.91

2.2

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

4710

19174

1.75

223.85

1.7

1027.39

1216.01

nmol/l

39.26

3629

14296

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

23753

141290

1.72

219.85

4.4

3.7

4.73

4.75

mmol/l

3.19

22430

131820

(3007853) Bacteria identified in Skin by Aerobe culture

3488

13032

1.88

218.76

1.9

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1844

5408

2.34

217.53

3.7

2.9

5.15

kpa

0.03

1752

5128

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3047

10897

1.95

217.51

2.6

2.2

59.37

41.91

u/l

0.34

2568

9377

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

23597

140225

1.70

217.04

4.3

3.7

1.50

1.48

mmol/l

5.88

22144

130119

(36660697) Celiac disease serology panel - Serum

2739

9444

2.02

216.59

1.2

1.1

—

(3009343) pH of Capillary blood

1818

5360

2.33

211.78

3.7

2.9

7.42

0.14

106

1163

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

17941

100648

1.50

203.80

3.4

3.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1754

5221

2.30

199.62

3.7

2.9

1.45

2.04

mmol/l

8.51

1344

3809

(3015377) Calcium [Moles/volume] in Serum or Plasma

8499

41160

1.52

197.04

3.0

3.5

2.36

mmol/l

0.19

7387

36845

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1263

3247

2.65

195.40

1.9

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2663

9493

1.95

190.47

2.0

2.2

378.31

385.62

nmol/l

1.02

2465

8803

(3014111) Lactate [Moles/volume] in Serum or Plasma

2642

9413

1.95

189.21

7.3

6.9

1.31

1.35

mmol/l

0.88

2600

9188

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3464

13483

1.80

188.73

5.9

4.6

1.04

1.03

mmol/l

1.55

3233

12526

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2147

7186

2.06

182.57

1.7

1.5

—

(3022145) Colonoscopy Study observation

3248

12589

1.80

178.76

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2187

7442

2.02

177.69

2.4

2.3

19.36

23.43

au/ml

1.12

170

697

(3022621) pH of Urine by Test strip

2267

7820

2.00

177.41

3.0

2.7

—

(3017732) Neutrophils [#/volume] in Blood

2250

7792

1.99

174.02

2.8

2.5

4.56

4.76

e9/l

0.35

1829

6607

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

544

877

4.17

173.40

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

557

916

4.08

173.16

1.4

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4307

18233

1.66

172.92

3.2

3.1

0.81

0.82

mmol/l

6.49

4051

17039

(3024522) Salmonella sp identified in Specimen by Organism specific culture

544

891

4.10

169.98

1.4

1.3

—

(3018418) pH of Serum or Plasma

7523

36473

1.50

167.65

4.1

3.5

7.40

1.52

951

8295

(3025468) Yersinia sp identified in Specimen by Organism specific culture

534

873

4.11

167.25

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

534

874

4.10

167.00

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

534

875

4.10

166.76

1.4

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2003

6769

2.03

165.39

1.3

1.2

53.87

52.15

au/ml

0.10

402

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1763

5740

2.10

160.49

1.5

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

7358

35842

1.49

158.45

3.4

2.8

7.24

7.85

mmol/l

23.70

6339

30256

(3000850) Epithelial cells [#/volume] in Urine

5574

25731

1.54

154.11

2.7

2.3

6.09

6.56

e6/l

1.59

5007

22528

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3006

11882

1.75

153.31

1.8

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

6697

32232

1.49

151.81

2.5

2.2

3363.07

5232.47

umol/l

3.80

5896

28372

(3011397) Hemoglobin [Presence] in Urine by Test strip

6175

29250

1.51

151.02

3.7

2.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2057

7252

1.95

150.37

2.4

2.0

6.98

8.44

ug/l

1.74

1747

6327

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3976

17049

1.63

149.80

2.1

1.9

29.99

29.85

0.67

3877

16553

(3037121) Protein [Mass/volume] in Urine

1127

3155

2.42

146.01

2.9

3.3

0.30

0.31

g/l

0.09

407

1534

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1695

5648

2.05

144.78

8.9

9.5

24.34

24.36

mmol/l

0.07

1662

5474

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

782

1829

2.88

143.59

1.4

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

976

2571

2.57

143.38

1.4

280.65

266.50

ug/g

0.76

561

1488

(3027945) Reticulocytes/100 erythrocytes in Blood

2903

11590

1.73

142.35

2.5

2.3

1.76

1.71

2.19

2590

10282

(3005322) IgE [Units/volume] in Serum or Plasma

1897

6730

1.93

135.69

1.4

1.2

173.12

246.67

u/ml

3.36

1772

6212

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2953

12000

1.70

135.49

1.8

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2114

7794

1.86

134.58

2.7

2.4

10.45

10.78

g/l

2.68

1940

7025

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1105

3185

2.35

134.18

2.4

2.2

330.76

578.41

ug/l

2.97

1041

2987

(3020682) Albumin/Creatinine [Ratio] in Urine

6964

34487

1.45

133.35

3.9

3.5

10.20

8.65

mg/mmol

1.39

4439

21205

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1167

3464

2.28

132.58

2.3

2.1

7.41

g/l

0.03

1063

3149

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1166

3461

2.28

132.46

2.3

2.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2593

10247

1.74

131.19

2.4

2.0

0.22

g/l

0.58

2428

9534

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1162

3459

2.28

131.12

2.3

2.1

3.69

3.83

g/l

2.23

1057

3143

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1118

3292

2.30

129.33

2.3

2.2

2.98

3.02

g/l

0.68

1013

2978

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1568

5288

2.02

129.28

2.5

2.3

—

(3023520) Reticulocytes [#/volume] in Blood

2134

8001

1.83

128.61

2.5

69.88

68.66

e9/l

0.77

1518

5662

(3004616) Nuclear Ab [Presence] in Serum

517

1002

3.46

128.40

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

3147

13190

1.65

128.08

1.5

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1191

3634

2.22

126.75

3.1

2.8

—

(3012516) Albumin [Mass/volume] in Urine

6607

32680

1.44

126.03

3.4

2.9

299.41

345.51

mg/l

0.40

4273

20310

(3002032) Base excess in Venous blood by calculation

2435

9581

1.75

124.76

4.2

3.3

1.88

1.82

mmol/l

0.34

2076

8255

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

895

2438

2.48

122.62

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1008

2902

2.35

122.60

1.3

1.2

46.54

38.19

u/ml

0.32

197

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2428

9614

1.73

121.53

4.2

3.3

5.85

5.81

kpa

0.94

2365

9379

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

770

1966

2.64

120.14

1.2

23.13

16.19

u/ml

—

(4146454) Self-monitoring of blood glucose

319

450

4.73

119.06

2.8

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2117

8103

1.79

118.90

2.4

66.44

66.49

g/l

0.10

1921

7428

(3035350) Ketones [Presence] in Urine by Test strip

12249

67684

1.35

118.42

3.8

3.0

0.00

estimate

0.63

2048

14488

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1493

5116

1.98

117.52

4.4

3.5

24.18

24.22

mmol/l

0.15

1465

5018

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2845

11895

1.65

116.17

4.0

3.8

234.56

245.42

u/l

3.63

2691

11299

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

937

2674

2.36

116.15

1.3

1.2

11.93

9.27

u/ml

0.37

144

381

(3012544) pH of Venous blood

2477

9985

1.70

116.04

4.1

3.3

7.36

7.38

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1088

3317

2.22

115.88

2.2

2.1

9.93

10.28

g/l

1.84

978

2985

(3017143) Hepatitis C virus Ab [Presence] in Serum

3502

15473

1.57

113.84

1.6

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

12247

67934

1.34

113.71

5.4

4.1

0.00

estimate

5.11

1915

13911

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

920

2633

2.36

113.30

1.3

1.2

5.14

11.48

u/ml

1.08

103

241

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1028

3095

2.24

112.77

2.2

2.4

0.64

0.80

g/l

0.82

914

2666

(3009261) Glucose [Presence] in Urine by Test strip

12350

68653

1.34

112.61

3.8

3.0

0.00

estimate

0.05

1887

13595

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

772

2048

2.54

111.62

1.2

3.22

7.76

u/ml

1.04

159

(3026782) Osmolality of Urine

5233

25320

1.45

109.87

3.0

2.5

530.43

547.98

mosm/kgh2o

6.08

4486

21421

(3000991) Gas panel - Venous blood

2347

9461

1.70

109.65

9.0

7.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1288

4289

2.03

109.54

1.7

1.6

1.52

g/l

0.03

1138

3624

(3002385) Erythrocyte distribution width [Ratio]

21327

128967

1.39

109.41

18.6

12.9

15.46

14.78

2.68

21101

125866

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

958

2849

2.27

108.11

2.2

2.1

37.85

37.71

g/l

0.30

853

2533

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1989

7698

1.76

107.20

3.3

3.5

4.49

4.54

pmol/l

1.00

1779

6945

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

939

2781

2.28

106.97

2.3

2.2

0.04

0.02

g/l

0.74

865

2553

(3013139) Helicobacter pylori Ag [Presence] in Stool

1982

7677

1.76

106.51

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3520

15833

1.54

105.04

1.8

1.6

1.52

1.36

22.88

3161

14007

(3020779) Urea [Moles/volume] in Serum or Plasma

2211

8871

1.70

104.88

7.5

5.7

9.28

9.54

mmol/l

0.90

2104

8443

(3004588) Protein electrophoresis panel - Serum or Plasma

1744

6551

1.81

103.72

2.3

2.2

—

(3028707) Methadone [Presence] in Urine by Screen method

645

1646

2.63

100.68

3.0

2.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

362

652

3.71

99.83

2.8

2.7

57.48

57.68

0.05

299

556

(3014576) Chloride [Moles/volume] in Serum or Plasma

3106

13749

1.56

99.13

7.8

6.8

104.45

mmol/l

0.01

3101

13742

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

880

2629

2.25

98.19

2.2

0.00

g/l

0.73

810

2406

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

636

1635

2.61

97.86

1.3

28.77

26.77

u/l

0.69

519

1388

(3044889) 12 lead EKG panel

16056

93755

1.31

96.96

3.6

3.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

869

2599

2.25

96.70

2.3

2.2

0.00

g/l

-0.00

808

2398

(3002256) Pathology report gross observation

3879

18106

1.48

96.43

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1632

6151

1.80

95.79

1.7

1.9

1.30

1.31

g/l

0.12

1488

5600

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

277

423

4.37

94.41

2.7

41457.80

41002.10

ug/l

0.14

277

423

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1348

4816

1.89

93.56

1.1

1.27

4.42

u/ml

0.96

(4200892) Spirometry reversibility

1896

7535

1.71

92.67

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1697

6551

1.76

91.82

1.1

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1120

3789

2.00

90.98

1.7

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

334

608

3.67

90.79

1.3

1.2

58.40

51.39

u/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

321

569

3.76

90.51

1.2

19.33

5.55

u/ml

0.87

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

975

3143

2.09

90.15

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

328

593

3.69

90.01

1.2

79.07

62.04

u/ml

0.33

(3021589) Normoblasts [#/volume] in Blood

10945

61087

1.30

89.54

8.9

8.6

0.00

e9/l

0.89

8847

48562

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

328

596

3.67

89.39

1.2

81.23

44.72

u/ml

1.26

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5643

28573

1.38

89.05

1.6

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

1949

7888

1.68

88.98

3.5

2.7

4.62

4.53

kpa

0.99

1890

7656

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4555

22271

1.42

87.92

2.7

3.2

2.45

mmol/l

0.08

3947

19344

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1198

4220

1.92

86.62

1.6

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

854

2674

2.15

84.99

1.5

1.4

18.90

14.13

iu/ml

0.28

(3015736) pH of Urine

9887

54821

1.30

82.99

3.5

2.8

5.94

5.87

1.16

772

4873

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3208

29458

0.68

81.60

3.9

4.1

22.82

22.01

1.79

1442

14187

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

248

396

4.17

80.12

1.1

9.63

8.83

u/ml

0.09

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3520

16689

1.45

79.46

2.2

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3914

18959

1.43

78.65

2.2

1.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2630

11838

1.52

76.59

7.7

7.1

12.94

12.71

kpa

1.18

2542

11263

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2630

11847

1.52

76.30

7.7

7.1

5.09

5.08

kpa

0.20

2544

11279

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4244

36744

0.72

75.57

4.8

4.6

4.33

3.02

ug/l

0.58

3893

32941

(3003396) Base excess in Arterial blood by calculation

2641

11958

1.51

74.70

7.7

7.0

0.75

0.90

mmol/l

1.05

2154

9589

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

433

1063

2.72

72.80

2.3

1.7

31.27

28.43

mg/l

0.33

122

335

(3045424) Erythrocytes [Presence] in Urine

578

1652

2.34

71.30

1.5

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1959

8380

1.59

71.28

3.3

2.2

66.51

69.37

ml/min/173m2

2.14

744

3393

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1144

4259

1.81

69.49

2.0

1.9

40.57

39.15

u/l

1.40

1021

3768

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

909

3147

1.94

69.00

1.8

1.6

0.23

0.24

g/l

1.11

852

3005

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2570

11763

1.49

68.69

3.3

4.2

16.73

29.70

ug/l

1.54

2006

9328

(3051611) Lipemic interference index of Serum or Plasma

461

1205

2.56

68.68

3.0

2.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1921

8286

1.57

67.34

2.3

2.5

193.58

201.70

ng/l

0.32

1727

7508

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

610

1831

2.23

67.25

1.8

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

876

3023

1.95

67.10

1.4

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

743

2423

2.06

66.55

1.3

501.40

541.26

mg/l

0.55

701

2322

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

446

1170

2.55

65.98

1.5

1.6

—

(3036180) Methadone [Presence] in Urine

221

378

3.89

65.48

2.6

1.6

—

(3016502) Oxygen saturation in Arterial blood

2310

10447

1.50

65.27

8.3

7.5

95.91

95.72

0.85

2250

10021

(3008757) Leukocyte morphology finding [Identifier] in Blood

361

857

2.81

64.59

3.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

405

1023

2.64

64.55

1.6

1.5

4210.91

9417.14

titre

0.47

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1731

7361

1.59

64.36

2.8

3.3

38.57

50.85

u/ml

1.98

1674

7132

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

915

3260

1.89

63.76

1.8

1.5

1.17

1.18

g/l

0.39

858

3126

(3007566) Smooth muscle Ab [Titer] in Serum

860

3003

1.92

63.64

1.2

134.08

145.53

titre

0.09

291

(3023323) Follitropin [Units/volume] in Serum or Plasma

1796

7729

1.57

63.47

1.4

1.3

27.20

28.15

iu/l

0.55

1551

6598

(3034770) Mitochondria Ab [Titer] in Serum

850

2972

1.92

62.66

1.2

1097.14

1198.72

titre

0.12

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1519

6299

1.63

62.54

2.5

2.0

5168.41

6742.36

u/l

1.27

622

2619

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1132

4345

1.75

62.01

1.5

10.52

13.73

u/ml

0.35

112

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

916

3315

1.86

60.83

1.5

1.6

218.71

275.44

titre

0.26

148

(40761535) Cells panel - Urine sediment

1782

7730

1.56

60.76

3.9

2.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

625

1975

2.12

60.76

1.4

1.2

—

(3025941) Bacteria identified in Stool by Culture

1667

7145

1.58

59.84

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

735

2486

1.98

59.60

1.7

1.5

12346.38

12938.16

e6/l

0.13

521

1736

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

189

310

4.05

59.16

1.3

—

(4034850) Laboratory test

384

5790

0.43

58.95

10.3

8.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

189

311

4.04

58.92

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

450

1255

2.39

58.63

1.9

1.6

6.00

4.27

titre

—

(3036489) Thrombin time

1154

4525

1.72

58.62

2.1

1.8

21.22

21.39

0.40

1027

3921

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

700

2358

1.99

57.41

1.2

30.58

46.59

u/ml

1.76

245

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

318

758

2.80

56.54

1.7

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1126

4434

1.71

56.31

1.3

1.2

1.14

0.65

u/ml

0.37

438

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

172

275

4.16

55.62

2.5

2.2

—

(40768443) Skin Pathology biopsy report

1280

5243

1.64

55.20

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

767

2706

1.90

55.04

2.2

2.0

12.01

10.28

mg/l

2.03

708

2556

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2215

10271

1.46

54.88

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2124

9790

1.47

54.24

1.2

142.89

151.90

iu/ml

0.43

745

3900

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

825

2995

1.85

54.24

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

885

3289

1.81

53.98

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

293

688

2.84

53.55

1.8

1.5

—

(3011288) Drugs identified in Urine by Screen method

925

3501

1.77

53.10

3.4

2.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1580

6885

1.55

52.62

10.3

8.9

0.65

0.67

1.26

1569

6853

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

908

3432

1.78

52.36

1.1

9.57

4.82

u/ml

0.87

585

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

190

346

3.65

51.82

1.8

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1574

6889

1.54

51.37

10.2

8.8

1.33

0.10

1561

6853

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

189

346

3.63

51.18

1.8

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

629

2127

1.98

51.05

1.2

3.73

3.67

mmol/l

0.80

588

2008

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

28.32

50.93

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

873

3293

1.78

50.68

1.4

87.53

129.56

pmol/l

3.97

854

3228

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

908

3469

1.76

50.48

2.5

2.1

181.73

187.40

1.07

863

3283

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

891

3386

1.77

50.44

1.6

19.83

2.70

iu/ml

0.46

183

725

(3004809) Band form neutrophils/100 leukocytes in Blood

478

1464

2.18

50.28

2.9

2.7

1.57

1.56

0.01

421

1311

(42529406) Shigella sp [Presence] in Stool by Culture

864

3259

1.78

50.16

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

861

3255

1.77

49.61

1.2

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

265

617

2.86

49.21

3.1

26.72

26.98

mu/l

0.04

248

596

(1761868) Lipid panel - Serum or Plasma

7670

58925

0.81

48.98

2.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1070

4331

1.66

48.25

1.9

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

426

1268

2.24

48.00

1.7

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

426

1269

2.24

47.91

1.7

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

920

3586

1.72

47.68

2.6

2.2

3.55

3.68

g/l

1.89

878

3411

(40761536) Microorganisms panel - Urine sediment

1631

15519

0.68

47.66

4.0

3.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

589

1998

1.97

47.40

2.7

2.2

32.88

35.06

umol/l

1.45

541

1792

(3044290) Cell count panel - Cerebral spinal fluid

636

2218

1.92

47.26

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

252

588

2.85

46.64

1.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

252

588

2.85

46.64

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

252

588

2.85

46.64

1.7

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

844

3236

1.75

46.35

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

155

265

3.89

46.10

1.9

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

155

265

3.89

46.10

1.9

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1308

5636

1.56

45.66

2.9

2.4

0.29

0.28

e6/l

0.06

1277

5444

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

156

271

3.82

45.44

1.9

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

581

1996

1.95

45.11

1.6

1.4

—

(3014271) Vancomycin [Susceptibility]

178

342

3.46

45.05

3.2

2.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2098

9986

1.42

44.86

8.8

7.8

119.22

122.00

g/l

8.30

2069

9684

(3024980) IgG subclass 4 [Mass/volume] in Serum

480

1547

2.07

44.43

1.5

0.69

0.80

g/l

1.21

382

1077

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

492

1602

2.05

44.32

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

290

756

2.55

43.60

3.1

2.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

291

761

2.55

43.48

1.6

1.3

1.59

1.33

promille

1.90

237

557

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

203

435

3.10

43.45

1.9

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

627

2246

1.87

43.00

1.4

1.3

15.01

24.61

u/ml

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

439

1386

2.11

42.87

1.3

0.16

0.26

nmol/l

1.40

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

626

2245

1.86

42.78

1.4

1209.15

1056.84

e6/l

0.14

495

1767

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1701

7853

1.46

42.77

7.5

6.1

24.92

24.73

mmol/l

1.25

1696

7768

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

439

1388

2.11

42.72

1.3

0.59

2.67

nmol/l

1.11

428

1322

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

625

2243

1.86

42.62

1.3

1.4

17.80

28.45

e6/l

0.89

470

1657

(3010838) Calcium [Moles/time] in 24 hour Urine

526

1782

1.97

42.52

1.9

5.43

5.27

mmol/24h

0.29

461

1606

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4678

25278

1.27

42.22

1.7

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

366

1084

2.25

41.79

6.7

5.4

11.36

11.41

mg/l

0.07

330

981

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1837

8649

1.43

41.61

1.9

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

184

382

3.20

41.45

1.6

1.5

7.10

ug/l

0.00

167

339

(3003338) MCHC [Mass/volume]

20791

130187

1.22

41.35

20.3

13.0

331.56

332.63

g/l

55.12

20680

129011

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

379

1146

2.20

41.20

1.2

58.07

63.31

u/l

0.97

344

1008

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

180

370

3.23

41.19

2.5

1.6

145.52

119.36

umol/l

0.50

182

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

627

2281

1.84

40.98

1.5

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5434

29989

1.25

40.71

2.0

1.8

—

(3003181) Sodium [Moles/volume] in Urine

491

1649

1.99

40.69

1.5

1.3

59.23

62.93

mmol/l

1.23

404

1287

(3008898) HLA-B27 [Presence]

1080

4576

1.58

40.49

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

405

1269

2.13

40.35

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

222

524

2.82

40.33

1.4

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2443

12139

1.36

40.30

7.5

5.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2311

11402

1.37

39.84

2.0

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

206

470

2.91

39.74

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

204

464

2.92

39.57

1.3

—

(3023410) Appearance of Cerebral spinal fluid

368

1125

2.18

38.99

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

922

3794

1.63

38.96

2.3

2.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

423

1377

2.05

38.20

1.2

49.75

50.33

u/ml

0.01

100

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

927

3841

1.62

38.10

2.3

1.9

93.24

92.04

0.80

890

3674

(3044927) Protein electrophoresis panel - Urine

270

731

2.46

37.65

1.3

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

377

1181

2.13

37.61

1.3

—

nmol/l

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

766

3039

1.69

37.25

3.4

3.1

44.54

43.98

mg/l

0.02

696

2178

(3034860) Kappa light chains.free [Mass/volume] in Serum

768

3051

1.68

37.16

3.4

3.1

44.77

64.89

mg/l

1.02

695

2193

(3004716) Salmonella sp identified in Stool by Organism specific culture

1556

7251

1.44

37.15

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

412

1348

2.04

36.72

5.6

4.6

358.62

363.00

umol/l

0.24

363

1140

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

111

175

4.21

36.69

1.6

1.4

0.38

0.45

ug/l

0.98

113

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

744

2945

1.69

36.49

3.4

3.1

1.92

2.29

ratio

0.25

163

(1001926) Buprenorphine [Presence] in Urine by Screen method

1005

4291

1.57

36.45

2.4

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

726

2863

1.70

36.10

1.4

—

(3024928) Oxygen saturation in Venous blood

599

2238

1.79

35.96

3.5

2.7

—

(3000492) Spirometry study

2588

13192

1.33

35.86

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4774

26290

1.24

35.86

1.5

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

485

1699

1.90

35.65

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

110

5.13

35.10

1.6

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1324

6056

1.47

34.80

1.1

226.46

221.30

titre

0.03

173

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

293

855

2.28

34.72

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

232

609

2.53

34.52

1.3

1.2

23.95

23.10

u/l

0.07

200

520

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

131

4.66

34.28

1.6

1.4

121.47

127.19

ng/l

0.10

131

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2559

21560

0.76

33.96

2.9

0.73

0.79

ug/l

1.32

1858

13839

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

235

626

2.50

33.95

1.3

1.2

87.63

83.55

u/l

0.26

207

542

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

241

650

2.47

33.93

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

242

656

2.45

33.72

1.3

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

836

3488

1.60

33.42

3.1

2.8

0.36

u/ml

0.11

474

1888

(3021788) Differential panel - Synovial fluid

579

2194

1.76

33.18

1.6

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

585

2225

1.76

33.10

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

500

1817

1.84

32.87

1.3

1.2

2.92

4.00

u/ml

2.83

223

813

(3047007) Chlamydophila sp Ab [Presence] in Serum

476

1715

1.85

32.16

1.3

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

371

1234

2.00

31.69

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

768

3180

1.61

31.68

1.9

15.68

10.43

iu/l

0.17

276

1253

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

998

4395

1.52

31.52

4.1

3.4

47.73

47.84

0.05

989

4355

(3023420) DNA double strand Ab [Units/volume] in Serum

395

1347

1.95

31.47

1.6

1.5

28.50

24.73

iu/ml

0.32

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

190

473

2.67

31.41

2.9

2.2

0.21

0.24

e9/l

1.10

163

394

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

402

1384

1.94

31.16

1.1

1.50

g/l

0.10

366

1254

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

555

2121

1.75

30.91

1.4

1.3

109.87

105.52

u/ml

0.25

103

514

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

874

3766

1.55

30.47

2.0

1.8

3.78

2.66

ug/l

0.79

762

3357

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

193

493

2.60

30.38

2.8

2.1

566.99

503.52

e6/l

0.92

163

393

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

318

1015

2.09

30.35

1.0

1.1

—

7.64

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

250

723

2.30

30.31

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

494

1839

1.79

30.08

1.2

160.00

90.32

titre

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

251

731

2.28

29.95

1.1

262.56

256.26

mg/l

0.07

222

629

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

259

765

2.25

29.92

1.1

42.16

44.03

mg/l

0.08

222

612

(3032057) Clostridioides difficile [Presence] in Stool

138

4.23

29.36

1.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

141

4.19

29.33

2.1

15.84

16.55

umol/l

0.20

141

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

7.03

29.25

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

998

4466

1.50

29.22

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

263

790

2.21

29.21

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

284

881

2.14

29.16

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

285

888

2.14

28.95

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

285

888

2.14

28.95

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

191

498

2.55

28.90

11.3

11.8

0.62

mmol/l

0.02

175

450

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

283

880

2.14

28.89

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

746

3140

1.59

28.79

2.7

2.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

284

887

2.13

28.68

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

282

879

2.13

28.63

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

543

2112

1.72

28.46

1.2

287.98

253.63

u/ml

1.84

348

1377

(3026389) Candida sp identified in Specimen by Organism specific culture

421

1518

1.85

28.44

1.3

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

107

200

3.55

28.37

2.9

2.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

521

2013

1.73

27.97

5.5

3.6

947.91

1577.03

iu/ml

0.22

207

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

149

348

2.84

27.76

2.5

2.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1246

5879

1.42

27.73

9.8

9.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

474

1789

1.77

27.61

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

635

2601

1.63

27.40

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

635

2601

1.63

27.40

1.3

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

298

966

2.05

27.37

1.4

1.3

6.52

7.07

g/l

1.52

225

574

(3028192) IgG subclass 2 [Mass/volume] in Serum

297

965

2.05

27.11

1.4

1.3

2.86

3.04

g/l

0.97

222

573

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

222

642

2.30

26.98

1.5

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

296

965

2.04

26.79

1.4

1.3

0.37

0.44

g/l

2.32

224

570

(21494755) Public health laboratory ask at order entry panel

2248

18710

0.78

26.61

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1024

4695

1.46

26.57

1.3

219.08

231.21

miu/ml

0.48

477

2321

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

365

1285

1.89

26.57

2.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

175

457

2.54

26.45

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

175

457

2.54

26.45

1.5

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

191

521

2.44

26.39

1.6

1.4

5.37

6.11

u/l

1.38

163

442

(3026250) Tacrolimus [Mass/volume] in Blood

125

272

3.05

26.31

37.4

31.5

7.29

7.51

ug/l

0.33

117

249

(3000764) Benzodiazepines [Presence] in Urine

1237

5889

1.41

26.17

2.3

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

134

306

2.91

26.00

27.4

23.2

112.23

128.76

ug/l

1.40

105

272

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

409

1504

1.81

26.00

2.8

2.1

684.35

4485.51

u/ml

1.96

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

313

1055

1.97

25.87

3.0

3.4

4.06

10.00

nmol/l

0.59

301

1028

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

480

1854

1.73

25.84

1.1

5.35

10.90

au/ml

2.12

151

(3028300) Cannabinoids [Presence] in Urine

1247

5959

1.40

25.81

2.3

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

120

258

3.09

25.77

2.0

1.9

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

239

728

2.18

25.74

1.0

301.24

289.91

mg/l

1.60

211

656

(3016879) Cocaine [Presence] in Urine

1151

5427

1.42

25.71

2.3

1.6

—

(3027008) Opiates [Presence] in Urine

1244

5947

1.40

25.69

2.3

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

162

414

2.60

25.57

1.9

1.6

1.21

1.24

nmol/l

0.09

118

354

(4062490) Immunoglobulin typing, IgG

292

964

2.01

25.57

1.4

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

174

462

2.50

25.45

1.1

2.03

9.67

nmol/l

1.65

119

(3013005) Retinol [Moles/volume] in Serum or Plasma

142

340

2.77

25.35

1.8

1.4

2.06

1.96

umol/l

0.63

136

318

(3035637) Corticotropin [Mass/volume] in Plasma

340

1189

1.90

25.28

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

703

3012

1.56

25.18

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

280

926

2.01

24.43

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

480

1884

1.70

24.42

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

183

512

2.37

24.00

1.3

1.2

65.71

106.67

titre

0.37

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

299

1021

1.95

23.86

1.2

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

524

2123

1.65

23.67

2.1

1.5

0.86

0.82

nmol/l

0.50

418

1876

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

187

533

2.33

23.56

1.4

1.6

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

343

1235

1.85

23.37

2.4

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

207

619

2.22

23.36

1.5

1.4

20.51

25.44

u/ml

0.84

121

(3020717) Zinc [Moles/volume] in Serum or Plasma

160

427

2.49

23.21

1.5

1.3

21.69

30.58

umol/l

2.91

154

402

(3004119) Hemoglobin [Mass/volume] in Venous blood

1318

6471

1.36

23.17

3.4

2.8

128.13

130.27

g/l

2.91

1288

6324

(3017181) Myelocytes/100 leukocytes in Blood

1818

9369

1.30

22.95

4.2

3.5

0.84

0.98

1.30

680

2903

(3028433) Virus identified in Specimen by Culture

113

252

2.98

22.90

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

332

1191

1.85

22.89

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

1748

8977

1.31

22.64

4.3

3.5

0.08

0.13

2.34

619

2518

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

457

1808

1.68

22.62

1.1

121.42

118.38

1.16

414

1616

(3048879) Bone marrow aspiration report

156

3.57

22.57

2.0

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

356

1312

1.81

22.54

1.1

96.15

95.47

0.17

340

1228

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

187

546

2.27

22.34

1.0

1.1

0.95

1.12

u/l

1.88

257

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

185

539

2.28

22.21

1.3

1.2

735.56

548.26

titre

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

170

477

2.37

22.20

1.8

1.6

129.82

138.74

0.87

164

449

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

176

502

2.33

22.17

2.1

1.4

—

(3037756) Immunofixation for Serum or Plasma

479

1933

1.65

22.01

1.8

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

546

2.26

21.95

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

479

1935

1.65

21.92

3.5

2.6

61.71

63.71

1.09

479

1924

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

482

1952

1.64

21.85

1.3

1.2

3.17

3.83

u/ml

0.41

168

672

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

213

663

2.13

21.84

1.8

2.2

18.68

18.82

nmol/l

0.07

200

635

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1056

5048

1.40

21.83

3.3

2.5

1.30

1.27

0.46

1051

5024

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

124

302

2.72

21.54

1.0

9.52

11.44

u/ml

0.26

204

(3048929) Epstein Barr virus Ab [Presence] in Serum

888

4134

1.44

21.30

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

110

253

2.88

21.18

1.3

40.07

40.02

g/l

0.01

135

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

21.17

1.0

0.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

339

1260

1.79

20.92

1.1

1.08

2.20

iu/ml

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1676

8650

1.30

20.90

4.0

3.4

0.63

0.68

0.42

630

2454

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

178

525

2.25

20.81

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

538

2267

1.58

20.78

3.6

3.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

113

3.93

20.53

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

188

574

2.18

20.26

2.0

1.5

101.23

97.64

0.69

172

530

(3009214) Lutropin [Units/volume] in Serum or Plasma

824

3824

1.44

20.12

1.3

12.07

9.71

u/l

4.22

673

3128

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

266

927

1.91

20.10

3.5

3.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.68

20.04

2.0

1.8

—

(3027944) Amphetamines [Presence] in Urine

1195

5922

1.35

19.80

2.2

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

214

697

2.04

19.57

1.6

1.5

6.23

6.48

u/l

0.10

184

525

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

122

311

2.60

19.49

1.2

1.3

0.31

g/l

0.36

242

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

195

615

2.11

19.40

1.6

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

277

993

1.85

19.24

2.5

2.6

1.33

1.32

g/24h

0.02

119

533

(3008037) Lactate [Moles/volume] in Venous blood

521

2220

1.56

19.22

2.9

2.7

1.44

1.62

mmol/l

5.07

506

2175

(3027273) Bicarbonate [Moles/volume] in Venous blood

1000

4843

1.38

19.16

3.7

2.9

25.20

25.26

mmol/l

0.20

976

4695

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.00

18.67

2.2

2.1

—

(3044941) Cell count panel - Synovial fluid

443

1834

1.61

18.48

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4515

26152

1.17

18.34

1.6

1.7

55946876.13

33111446.55

pmol/l

1.28

3809

21591

(3011412) CD3 cells [#/volume] in Blood

239

831

1.91

18.24

2.7

2.1

1.36

1.12

e9/l

2.84

209

746

(3009015) Lactate [Moles/volume] in Synovial fluid

4.68

18.15

1.3

6.11

5.40

mmol/l

0.35

(3024263) Appearance of Synovial fluid

165

501

2.19

18.08

1.5

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

4.72

17.95

8.9

6.4

61.91

70.67

0.75

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

111

282

2.61

17.89

1.2

111.31

109.92

0.20

101

249

(3016038) Potassium [Moles/volume] in Urine

193

627

2.04

17.83

1.3

1.1

33.17

35.38

mmol/l

0.62

163

543

(1761482) Bacteria [#/volume] in Urine by Culture

646

2933

1.47

17.74

4.6

3.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

307

1167

1.75

17.65

1.2

22.20

21.57

nmol/l

—

(3012501) Base excess in Blood by calculation

333

3604

0.61

17.61

3.4

3.7

2.43

2.54

mmol/l

0.34

241

2403

(3013290) Carbon dioxide [Partial pressure] in Blood

334

3604

0.61

17.45

3.4

3.7

4.97

4.99

kpa

0.27

329

3524

(3027315) Oxygen [Partial pressure] in Blood

335

3612

0.61

17.44

3.5

3.7

8.85

8.66

kpa

1.05

330

3532

(3029075) Extractable nuclear Ab panel - Serum

119

318

2.48

17.36

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

237

2.74

17.35

1.9

1.3

2091.29

2050.36

u/ml

0.01

(3000093) Morphology [Interpretation] in Blood Narrative

246

879

1.86

17.32

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

497

2149

1.54

17.24

3.0

2.8

7.47

7.68

mmol/l

0.57

483

2108

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

270

995

1.80

17.24

4.3

3.3

45.11

70.44

u/ml

0.80

264

988

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

851

4087

1.39

17.18

3.1

3.6

454.01

3106.99

u/ml

1.07

726

3507

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

215

737

1.94

17.14

1.2

1.98

2.08

mmol/l

0.60

197

687

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

265

978

1.80

16.85

1.4

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

762

3611

1.41

16.64

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

198

668

1.97

16.54

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

188

2.93

16.52

1.1

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

218

763

1.90

16.37

2.5

1.9

39.36

38.95

0.14

212

753

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

112

3.55

16.13

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

127

363

2.32

16.08

1.2

1.1

—

(4035726) Immunohistochemistry procedure

2131

11670

1.23

16.00

1.4

1.3

—

(3025159) Blasts/100 leukocytes in Blood

1627

8655

1.26

15.91

4.3

3.6

0.09

0.26

1.25

505

2229

(3045142) Bone marrow Pathology biopsy report

280

1072

1.74

15.77

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

450

1943

1.54

15.76

1.1

4.86

2.91

u/ml

0.87

177

1113

(3042733) HLA Ab [Presence] in Serum

227

2.69

15.74

5.1

5.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

543

2451

1.48

15.42

1.1

5.63

5.51

u/ml

0.05

273

1148

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

196

2.81

15.39

1.3

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

130

383

2.25

15.39

2.7

2.3

40.03

39.26

0.14

204

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

169

554

2.02

15.32

1.2

1.1

17.04

22.22

u/l

1.35

156

487

(3042517) Benzodiazepines panel - Urine

4.03

15.27

1.2

3.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

433

1869

1.54

15.20

3.1

3.0

0.78

0.82

nmol/l

0.90

318

1489

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

169

556

2.02

15.18

1.2

1.1

73.56

82.60

u/l

1.27

155

483

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

122

3.31

14.86

1.8

1.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

126

372

2.25

14.86

1.8

1.7

141.62

154.66

0.99

121

342

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

156

504

2.05

14.72

1.0

34.91

42.80

ng/l

2.17

115

393

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

155

500

2.06

14.69

1.0

547.31

331.09

ng/l

0.46

115

396

(3023419) Bacteria identified in Sputum by Culture

333

1363

1.62

14.66

2.7

2.1

—

(3034426) Prothrombin time (PT)

122

358

2.26

14.60

1.3

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

126

375

2.23

14.59

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1081

5524

1.31

14.54

1.6

296.95

298.47

mu/l

0.05

984

4879

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

197

695

1.88

14.51

1.3

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

557

2563

1.45

14.36

3.0

2.9

24.50

24.88

mmol/l

1.46

542

2507

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

238

894

1.77

14.36

1.2

155.37

192.60

titre

0.34

146

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

122

361

2.24

14.33

1.1

1.2

115.89

107.98

1.35

112

325

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

121

357

2.25

14.31

1.1

96.41

92.69

0.55

156

(40762814) Titanium [Mass/volume] in Blood

153

2.99

14.30

2.3

2.4

3.67

3.57

ug/l

0.05

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

139

435

2.12

14.26

1.6

1.5

2432071.58

1566317.64

iu/ml

0.28

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

525

2394

1.46

14.20

1.7

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

210

764

1.82

14.08

1.1

7.70

9.54

iu/ml

0.56

233

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

154

504

2.03

14.07

1.0

781.48

697.48

ng/l

1.49

112

383

(3019150) Specific gravity of Urine by Refractometry

4624

27305

1.14

14.05

4.5

3.2

1.02

kg/l

0.59

818

4109

(21494890) Protein electrophoresis panel - 24 hour Urine

248

949

1.74

14.05

2.3

2.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

236

891

1.76

14.01

1.2

510.00

161.29

titre

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

215

792

1.80

13.86

1.1

—

(21494434) Karyotype in Bone marrow

194

693

1.86

13.79

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

105

3.41

13.75

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

118

352

2.22

13.63

1.1

1.2

101.23

94.00

0.93

158

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

277

1104

1.67

13.56

4.8

5.2

46.98

94.23

u/ml

1.81

407

(3008295) Osmolality of Serum or Plasma

260

1020

1.69

13.50

1.4

1.3

278.74

278.87

mosm/kgh2o

0.03

200

805

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.31

13.50

1.9

1.6

43.90

44.77

umol/l

0.06

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

180

634

1.88

13.37

1.3

—

(3011985) Renin [Units/volume] in Plasma

351

1493

1.56

13.22

1.5

64.52

61.92

mu/l

0.06

320

1323

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

112

3.25

13.09

1.6

1.5

300006.74

558954.84

nmol/l

0.35

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

239

925

1.72

13.05

1.5

1.4

—

(3010421) pH of Blood

419

4039

0.68

12.96

3.5

3.6

7.42

0.27

367

3814

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

239

927

1.71

12.96

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

198

727

1.81

12.94

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

197

723

1.81

12.89

1.1

—

(3025130) Human papilloma virus identified in Specimen

516

2392

1.44

12.84

1.8

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

413

1836

1.50

12.73

1.2

—

(40768793) Breast Pathology biopsy report

680

3313

1.37

12.69

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

201

747

1.79

12.64

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

514

2394

1.43

12.49

1.1

1.36

1.17

u/ml

0.24

219

917

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

212

804

1.75

12.46

1.4

1.3

11.95

12.03

umol/l

0.06

201

771

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

237

2.43

12.34

1.9

1.4

60.84

35.80

u/l

0.49

212

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

663

3233

1.37

12.32

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

262

2.35

12.28

1.5

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

218

2.49

12.24

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

106

317

2.22

12.22

1.3

1.4

14.23

15.06

pmol/l

0.62

271

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

327

1401

1.55

11.99

1.4

1.3

398.65

300.76

pmol/l

0.86

282

1220

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

587

2822

1.38

11.92

1.1

1.26

2.32

u/ml

2.02

293

1304

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

206

786

1.74

11.88

1.3

1.2

1.27

1.74

u/ml

0.28

122

347

(37021550) Renin [Units/volume] in Plasma --upright

167

2.70

11.85

1.3

75.28

60.61

mu/l

0.18

132

(3028626) Oxygen [Partial pressure] in Capillary blood

526

2485

1.41

11.83

3.1

2.7

8.39

8.23

kpa

1.18

518

2428

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

235

2.40

11.71

1.7

1.5

9.26

9.25

ug/l

0.00

235

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

124

2.99

11.71

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

107

3.16

11.63

2.2

2.9

0.96

0.55

u/field

1.31

107

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

178

657

1.80

11.50

1.3

1.2

4.65

5.64

umol/l

3.26

166

620

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

291

2935

0.65

11.39

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

119

3.01

11.39

1.1

1.0

0.01

0.81

u/ml

1.31

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

6.09

11.36

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

184

690

1.77

11.29

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

219

2.42

11.27

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

326

1416

1.53

11.27

1.6

1.5

47.39

57.43

4.10

217

874

(3001964) Herpes simplex virus Ag [Presence] in Specimen

105

324

2.15

11.27

1.4

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

140

482

1.93

11.22

1.3

1.2

143.22

164.25

mmol/24h

2.64

140

482

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

157

564

1.85

11.08

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

114

3.02

11.07

2.0

1.2

—

(3019174) dRVVT (LA screen)

3.53

11.04

1.2

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

156

562

1.84

10.92

1.2

1.1

5.85

3.68

iu/ml

0.43

(3017817) Protein [Mass] in Urine collected for unspecified duration

215

851

1.68

10.91

2.5

2.3

—

0.88

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

290

2.19

10.87

1.1

4.16

6.27

u/ml

0.24

165

(3009871) Measles virus Ab [Titer] in Serum

116

379

2.03

10.77

1.8

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

212

841

1.67

10.69

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

188

723

1.73

10.61

6.3

7.3

—

(3002619) Bacteria identified in Specimen by Culture

234

2.32

10.59

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

214

2.38

10.54

1.2

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

165

612

1.79

10.53

1.1

1.2

12.61

22.75

u/ml

0.40

(3034274) Bile acid [Moles/volume] in Serum --fasting

472

2237

1.40

10.48

2.0

2.2

7.11

5.71

umol/l

0.80

338

1632

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.19

10.45

3.6

2.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

215

2.37

10.44

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

231

944

1.62

10.40

1.2

1.1

347.19

396.99

nmol/l

3.01

197

796

(40767503) Oxygen content in Capillary blood by calculation

323

3130

0.68

10.37

2.4

2.3

16.71

16.43

0.63

167

1441

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

198

778

1.69

10.36

1.8

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

620

3078

1.34

10.33

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

418

1945

1.43

10.30

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.90

10.20

1.3

—

(3036603) Volume of Urine

192

754

1.69

10.08

1.6

1.5

2103.02

1910.61

0.74

184

744

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

135

477

1.88

10.07

1.5

2.63

5.38

nmol/l

1.40

118

403

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

215

2.34

10.03

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

3.68

10.02

1.1

0.38

1.66

u/ml

0.78

(3010144) Erythrocytes [#/volume] in Synovial fluid

234

969

1.60

10.01

1.5

1.3

100199.39

97240.09

e6/l

0.02

163

661

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.14

9.98

1.5

1.6

1.85

1.86

mg/l

0.00

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

2.86

9.96

5.2

4.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

306

2.10

9.91

1.3

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

117

396

1.96

9.90

6.2

14.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

375

1727

1.44

9.80

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

223

2300

0.64

9.78

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

3.13

9.73

1.2

1.1

—

(40768441) Liver Pathology biopsy report

198

794

1.65

9.64

1.3

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

151

2.59

9.59

1.5

1.2

0.36

0.30

nmol/l

0.32

101

(3038177) Helicobacter pylori Ab [Presence] in Serum

469

2259

1.38

9.52

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

142

520

1.81

9.50

2.0

2.2

95.82

146.39

ug/min

0.34

(3024471) HLA-A [Type]

242

2.22

9.47

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

277

1210

1.52

9.42

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

205

2.33

9.40

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

201

2.34

9.39

1.0

1.1

0.48

0.69

u/ml

0.63

188

(3028271) Lactate [Moles/volume] in Capillary blood

241

2423

0.66

9.38

1.8

1.7

1.63

1.77

mmol/l

2.08

233

2371

(40768800) Prostate Pathology biopsy report

230

2332

0.65

9.33

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

493

2404

1.36

9.28

1.1

1.11

1.98

u/ml

2.70

252

1062

(3020911) Cortisol [Moles/time] in 24 hour Urine

108

364

1.97

9.28

1.3

85.63

331.29

nmol/24h

1.51

108

364

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

106

355

1.98

9.27

1.1

221.74

377.48

ng/l

0.32

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

750

3885

1.29

9.25

3.7

4.4

1.63

1.65

0.13

725

3597

(3000034) Microalbumin [Mass/volume] in Urine

194

783

1.64

9.23

3.0

2.8

59.65

43.80

mg/l

0.45

141

531

(3024932) HLA-DR beta [Type]

232

2.23

9.23

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

211

2.29

9.23

1.2

302.39

335.63

pmol/l

0.29

161

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

486

2369

1.36

9.18

1.7

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

220

2.26

9.17

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

3.31

9.15

1.2

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

106

2.87

9.08

11.1

8.4

6.26

5.20

mmol/l

0.56

106

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

213

2.27

9.04

1.0

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

0.92

0.53

mg/l

0.37

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

2.54

2.80

mg/l

0.08

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

3.84

3.81

mg/l

0.01

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

1.23

0.70

mg/l

0.35

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

2.87

2.67

mg/l

0.04

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

2.29

3.81

mg/l

0.46

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

1.50

1.90

mg/l

0.17

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

2.15

1.10

mg/l

0.47

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.03

9.04

1.5

1.6

2.60

2.40

mg/l

0.05

(3047352) Trisomy 18 risk [Likelihood] in Fetus

606

5195

0.77

9.01

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

108

369

1.94

8.95

3.1

2.9

29.04

28.07

umol/l

0.26

274

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

3.75

8.83

1.1

1.0

0.07

0.13

u/ml

0.21

(3033705) Calcium.ionized [Moles/volume] in Venous blood

287

1282

1.49

8.82

2.2

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

624

5306

0.77

8.72

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1446

11259

0.84

8.70

3.3

3.7

1.23

mmol/l

1.01

1286

9541

(3011841) English Walnut IgE Ab [Units/volume] in Serum

3.36

8.61

1.1

0.02

2.63

u/ml

1.01

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

173

2.37

8.50

1.3

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

149

2.49

8.48

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

611

5186

0.77

8.43

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

126

463

1.80

8.40

2.4

2.3

51.38

50.68

umol/l

0.08

108

384

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

455

2228

1.36

8.39

3.2

3.3

30.04

42.15

u/ml

1.57

436

2144

(3020491) Glucose [Moles/volume] in Blood

215

913

1.56

8.36

1.4

1.9

6.65

6.61

mmol/l

0.05

131

744

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.78

8.36

5.7

4.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

169

677

1.66

8.33

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

217

2.20

8.31

2.8

1.7

228.61

1704.81

e6/l

0.67

108

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

452

2217

1.35

8.26

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

166

664

1.66

8.24

3.3

3.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

105

2.78

8.20

1.0

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.31

8.19

2.8

2.5

81.47

67.46

pmol/l

0.08

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

232

2.14

8.13

1.1

63.33

75.68

0.90

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.04

8.11

1.6

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

220

947

1.54

8.08

2.0

2.47

2.00

u/field

0.50

101

384

(3006245) CD3-CD19+ cells/100 cells in Blood

300

1.99

8.04

2.8

1.9

9.65

10.01

0.10

287

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.81

8.01

1.5

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

381

1828

1.38

8.00

1.8

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

355

1683

1.40

8.00

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5918

36445

1.09

7.96

1.6

1.38

1.34

mmol/l

2.89

5187

29783

(3007930) Methemoglobin/Hemoglobin.total in Blood

729

3838

1.26

7.95

3.8

4.5

0.86

0.91

2.88

703

3551

(3042111) Morphology [Interpretation] in Bone marrow Narrative

335

1575

1.41

7.92

1.5

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

4.07

7.88

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

329

1544

1.41

7.86

1.4

1.3

37.16

29.28

u/l

0.41

289

1318

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.99

7.84

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

108

2.70

7.81

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

115

421

1.81

7.80

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

504

2540

1.32

7.71

1.4

0.35

0.45

nmol/l

2.01

401

2015

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

109

2.67

7.69

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

598

3090

1.29

7.60

4.0

2.7

1.50

1.48

mg/l

0.27

564

2837

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

445

2209

1.34

7.56

2.6

4.0

118.46

1168.77

u/ml

2.55

406

2026

(1002224) Polysomnography panel

1055

5816

1.21

7.51

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

102

365

1.85

7.45

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

168

693

1.61

7.44

2.4

1.9

74.80

73.05

0.84

162

675

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.88

7.40

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

120

453

1.76

7.38

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.66

7.28

1.0

1.1

—

(3014891) Appearance of Pleural fluid

109

2.61

7.22

1.5

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.75

7.19

1.5

1.2

55.65

49.29

mg/l

0.31

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

2.11

7.09

1.0

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.11

7.04

1.3

0.93

1.37

ml/s/173m2

1.09

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

149

608

1.62

6.93

1.7

2.73

2.54

u/field

0.12

106

479

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.20

6.89

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1015

5625

1.20

6.87

1.6

3.32

3.69

mg/l

0.86

778

3857

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

240

2.02

6.84

1.1

82.88

84.83

0.11

(3011648) Oxygen content in Venous blood

210

932

1.49

6.78

3.0

2.0

11.15

11.09

0.07

210

932

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.14

6.71

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

142

2.33

6.69

1.1

1.2

5.62

9.38

u/ml

0.29

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

204

903

1.50

6.68

1.3

1.37

1.40

nmol/l

0.15

177

817

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

220

2.05

6.66

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

256

1186

1.43

6.65

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

156

652

1.59

6.60

2.2

2.0

4.30

3.56

ug/l

0.31

143

598

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

356

1.81

6.60

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

6.62

6.60

1.3

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

3.63

6.54

1.1

19.86

28.96

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.63

6.54

1.1

35.50

18.00

u/ml

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

277

1.91

6.51

1.0

1.1

6.14

6.11

mg/g

0.01

265

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

299

1431

1.39

6.47

1.5

1.4

—

(40768446) Kidney Pathology biopsy report

102

383

1.77

6.45

1.8

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

5244

37117

0.92

6.44

4.4

3.3

0.00

estimate

0.00

1891

13271

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

120

2.43

6.43

1.3

157.32

112.12

ng/l

0.23

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

385

1920

1.33

6.42

1.1

49.46

534.82

iu/ml

0.80

423

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

348

1712

1.35

6.36

1.0

0.50

0.46

u/ml

0.05

344

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

262

1230

1.41

6.35

1.2

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.54

6.34

1.1

32.43

19.29

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

104

396

1.74

6.28

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2777

16681

1.11

6.11

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

149

2.22

6.04

1.8

2.2

—

(3047189) Immunofixation for 24 hour Urine

117

466

1.66

6.03

1.8

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

812

0.54

5.98

1.6

1.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

133

2.29

5.95

1.1

1.2

0.32

1.73

u/ml

0.63

128

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2096

15460

0.89

5.93

2.9

3.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.60

5.90

1.2

49.56

56.06

0.27

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

157

676

1.54

5.90

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1525

11471

0.87

5.89

1.6

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

173

2.11

5.84

1.1

0.64

0.97

umol/24h

0.44

(3022689) Creatine [Moles/volume] in Urine

246

1.91

5.81

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

5.77

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

887

0.57

5.75

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

664

5332

0.82

5.71

1.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

179

800

1.48

5.67

2.1

1.7

3.88

3.89

mg/l

0.01

170

752

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

108

1147

0.62

5.62

1.5

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

411

2111

1.29

5.60

1.1

1.0

5.34

4.21

u/ml

0.49

188

921

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

397

2031

1.30

5.58

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

581

4712

0.81

5.53

1.6

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.17

5.44

1.1

—

(3006462) Nitrate [Presence] in Urine

145

626

1.54

5.42

3.4

2.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.84

5.34

1.1

0.01

9.74

u/ml

0.65

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.84

5.34

1.1

0.02

2.17

u/ml

0.78

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

159

704

1.50

5.30

1.6

1.4

13.65

12.30

u/l

1.06

154

683

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

274

1.81

5.27

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

813

0.57

5.24

1.6

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

175

793

1.46

5.21

1.1

1.2

1.07

ratio

0.07

372

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

148

649

1.51

5.18

1.1

—

(3000012) Reticulocyte production index

194

1802

0.71

5.16

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

485

2572

1.25

5.14

1.5

1.4

—

(3001556) Androgen free Index in Serum or Plasma

2.41

5.12

1.3

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

285

1410

1.34

5.12

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

156

2.08

5.10

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.75

5.07

1.3

1.0

14.31

13.83

nmol/l

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

352

1800

1.30

5.02

1.5

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

175

1645

0.70

5.01

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.16

4.96

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

105

431

1.61

4.91

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

128

2.17

4.88

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

871

0.60

4.87

1.5

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

124

2.19

4.85

2.2

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

210

1.89

4.84

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

210

1.89

4.84

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

210

1.89

4.84

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

210

1.89

4.84

1.1

—

(3025577) Chromium [Mass/volume] in Blood

145

644

1.49

4.81

2.2

2.1

2.42

ug/l

0.00

112

554

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.40

4.80

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

389

1.64

4.74

2.1

1.8

8.93

9.81

mg/l

0.88

300

(21491868) Cryoglobulin [Mass/volume] in Serum

374

1.65

4.73

1.2

1.1

0.24

0.23

g/l

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

241

1.81

4.69

1.3

1.2

128.54

129.03

nmol/l

0.01

176

(3022493) Free Hemoglobin [Mass/volume] in Plasma

103

427

1.60

4.65

2.5

3.8

62.55

4980.07

mg/l

2.82

298

(3036071) Salmonella sp Ab [Titer] in Serum

100

412

1.61

4.63

1.2

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

283

0.33

4.59

2.6

2.9

13.71

14.82

ml/dl

1.23

267

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.82

4.54

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.38

4.53

2.4

1.3

—

(3017704) Immunofixation for Urine

102

425

1.59

4.52

2.1

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.51

4.50

2.8

4.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

192

912

1.40

4.50

1.1

—

(3018133) Calcium [Moles/volume] in Urine

124

2.14

4.49

2.8

1.6

2.41

2.68

mmol/l

0.33

110

(3028308) Erythrocytes [#/volume] in Pleural fluid

241

1190

1.34

4.45

1.5

1.4

76699.73

48546.16

e6/l

0.62

152

657

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

104

439

1.57

4.38

2.8

8.28

8.35

mg/l

0.04

334

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

145

658

1.46

4.37

2.6

1.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.06

4.34

2.4

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

131

2.07

4.29

1.1

1.2

—

(1616796) Gas panel - Central venous blood

376

3100

0.80

4.28

3.2

3.5

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

127

2.09

4.25

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2938

18013

1.09

4.25

1.8

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

260

1.73

4.20

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.34

4.16

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

252

1267

1.32

4.14

1.5

1.4

5595.12

2396.71

e6/l

0.41

183

860

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.41

4.13

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

151

699

1.43

4.12

1.2

—

(44813793) Dust mix specific IgE antibody measurement

185

889

1.38

4.09

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.13

3.98

2.2

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

100

2.19

3.95

1.1

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.73

3.94

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.21

3.92

1.1

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.65

3.92

1.0

40.94

46.49

u/l

0.24

(1617658) Protocol used for examination of sentinel lymph nodes

227

1135

1.33

3.91

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

260

1328

1.30

3.85

2.0

1.8

21.44

26.55

ug/l

0.59

253

1309

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

110

2.11

3.85

3.7

2.2

1.40

1.32

mg/l

0.07

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

791

6028

0.86

3.80

1.6

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.54

3.79

1.1

0.14

0.39

u/ml

0.36

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

119

537

1.47

3.75

2.1

2.3

302.32

204.64

ug/l

0.15

114

511

(3002523) Influenza virus A Ag [Presence] in Specimen

449

2454

1.21

3.72

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

375

2017

1.23

3.63

1.1

1.0

3.89

5.70

u/ml

1.42

144

779

(3022806) Fractional oxyhemoglobin in Capillary blood

229

1959

0.77

3.62

1.7

90.49

89.58

1.86

223

1929

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

122

2.01

3.62

1.9

1.6

2.02

1.86

mg/l

0.24

100

(40765096) Chromosome analysis panel by Banding

233

1.71

3.57

1.1

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.14

3.55

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

103

457

1.49

3.55

2.6

2.0

14.44

45.03

umol/l

2.23

(3003740) Influenza virus B Ag [Presence] in Specimen

447

2456

1.21

3.53

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

5.96

3.51

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.18

3.49

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

161

779

1.37

3.48

1.4

5.37

5.49

mmol/l

0.83

153

735

(3019897) Erythrocyte distribution width [Ratio] by Automated count

300

2472

0.80

3.48

2.5

2.3

13.22

13.13

0.98

300

2433

(40757373) Influenza virus identified in Isolate

157

1.86

3.46

1.8

1.3

—

(40768806) Pleura Pathology biopsy report

235

1205

1.29

3.43

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

340

1.56

3.37

2.1

1.6

2116.79

3325.17

e6/l

0.20

210

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

126

1.94

3.34

1.1

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

359

0.50

3.33

5.6

6.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

359

0.50

3.33

2.8

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8386

53606

1.05

3.31

4.1

3.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

179

1.78

3.30

1.5

1.3

25.72

22.62

0.26

144

(3013336) Amino acids [Identifier] in Serum or Plasma

4.73

3.29

1.9

3.0

—

(40762887) Creatinine [Moles/volume] in Blood

4.73

3.29

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

110

504

1.45

3.26

1.2

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.72

3.25

2.6

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

7.72

3.25

1.0

—

(3012441) Differential panel - Pleural fluid

230

1186

1.29

3.24

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

220

1.69

3.23

1.1

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

136

649

1.39

3.23

17.2

16.1

1355.63

3750.78

nmol/l

0.51

128

626

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

142

1.87

3.21

1.6

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.07

3.20

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

2.92

3.19

3.9

11.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

138

1.87

3.17

2.9

2.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

314

1.56

3.16

1.9

1.5

6386.19

7811.10

e6/l

0.18

149

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.19

3.16

1.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.59

3.12

1.0

0.66

0.16

u/ml

0.34

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

137

660

1.38

3.09

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

434

1.47

3.07

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

397

1.48

3.05

2.3

107.50

162.25

au/ml

0.78

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.36

3.03

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

339

1.52

3.02

1.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

6.62

3.01

1.1

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

6.62

3.01

1.1

1.0

1165.71

1364.29

titre

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

3.07

3.00

5.6

6.1

0.27

0.21

mmol/l

0.38

(3028717) Thiamine [Mass/volume] in Blood

2.06

2.98

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

107

988

0.72

2.94

1.2

1.3

143.47

178.02

pmol/l

2.74

107

988

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.08

2.94

2.1

0.84

1.47

mmol/l

1.28

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.76

2.92

1.1

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

394

0.55

2.92

1.4

2.62

2.59

0.01

338

(3050794) Legionella sp Ab [Presence] in Serum

2.04

2.90

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

207

1.66

2.89

1.5

1.2

27.24

54.22

g/l

0.50

169

(3049233) Organic acids panel - Urine

7.94

2.88

1.2

1.0

—

(3000285) Sodium [Moles/volume] in Blood

119

1.89

2.88

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

158

1.76

2.85

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

312

1.53

2.85

1.8

1.6

126.98

158.16

au/ml

—

(3003434) Protein [Mass/volume] in Pleural fluid

272

1457

1.24

2.84

1.5

1.4

32.70

33.61

g/l

0.53

245

1319

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.31

2.82

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.68

2.79

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

109

516

1.40

2.77

5.8

3.9

222.22

358.76

u/ml

0.22

(3035320) C reactive protein [Mass/volume] in Body fluid

195

1010

1.28

2.72

2.4

2.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

795

5907

0.89

2.71

1.5

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

227

1.60

2.69

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6211

39594

1.05

2.68

3.5

2.8

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

6.62

2.63

1.0

—

(3003694) ABO and Rh group [Type] in Blood

6931

44319

1.05

2.61

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

803

5945

0.89

2.60

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

801

5931

0.89

2.59

1.5

1.4

—

(3018572) Chloride [Moles/volume] in Blood

283

2265

0.83

2.58

5.3

5.7

105.62

105.13

mmol/l

1.09

261

2004

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.34

2.58

1.2

1.6

1.08

1.10

u/field

0.02

(3039000) Anion gap in Blood

283

2264

0.83

2.57

5.3

5.7

11.34

11.27

mmol/l

0.12

261

2003

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.96

2.57

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

803

5939

0.89

2.56

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

118

575

1.36

2.55

1.1

99.24

94.64

0.91

440

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2819

17606

1.07

2.55

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

111

1.85

2.49

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

405

1.42

2.47

1.3

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

126

1.79

2.46

2.0

1.7

1.16

1.20

mmol/l

1.79

118

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

450

2564

1.16

2.46

2.2

141.96

117.51

ug/min

0.47

255

1521

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

3.31

2.43

2.3

2.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

4.63

2.41

1.0

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.25

2.39

1.1

1.4

43.64

32.53

0.46

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.14

2.37

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.14

2.37

1.1

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

630

3688

1.13

2.36

1.7

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

860

6304

0.90

2.36

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.91

2.32

5.2

6.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

102

494

1.37

2.32

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

145

741

1.30

2.30

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

105

513

1.36

2.27

1.2

1.3

35.33

66.77

—

(3007542) Rye IgE Ab [Units/volume] in Serum

2.13

2.25

1.0

1.1

0.83

0.22

u/ml

0.39

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

413

2358

1.16

2.24

2.6

2.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

4.96

2.22

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

4.96

2.22

1.2

1.1

1.85

1.13

mg/l

—

(3032641) Amino acids panel - Urine

4.96

2.22

1.2

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.65

2.21

11.3

7.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.10

2.17

1.6

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

157

1.64

2.16

1.8

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.85

2.14

2.5

2.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.46

2.09

1.2

1.0

0.31

0.35

umol/24h

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.86

2.09

1.2

134.73

114.58

ug/l

0.19

(3024869) Neuronal Ab [Presence] in Serum

154

1.63

2.07

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2257

15808

0.94

2.07

1.6

1.7

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

5.51

2.04

1.0

18.36

41.17

nmol/24h

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.84

2.03

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.03

2.02

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.98

2.01

1.0

1.6

—

(3020650) Glucose [Presence] in Urine

520

0.69

2.01

1.6

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

278

1.45

2.00

1.2

146.19

224.07

ug/l

0.44

144

(3020874) Milk IgE Ab [Units/volume] in Serum

172

917

1.24

1.99

1.0

1.1

1.91

2.11

u/ml

0.05

250

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.16

1.98

1.1

8.60

8.65

mmol/l

0.04

(3015183) Erythrocyte sedimentation rate

146

765

1.26

1.96

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

242

0.55

1.96

6.6

6.3

—

(3019060) Gas panel - Arterial blood

1090

6648

1.09

1.94

4.5

4.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.95

1.92

1.6

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

373

2143

1.15

1.91

1.4

6.87

6.88

mmol/l

0.02

328

1918

(3004451) EKG impression Narrative

628

0.73

1.87

1.4

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

279

1571

1.18

1.86

1.4

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

4.73

1.86

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

4.73

1.86

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

472

3523

0.88

1.86

4.0

2.9

22.45

26.88

mg/l

1.86

276

2324

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

844

0.77

1.83

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

482

1.32

1.81

1.1

—

(3012565) Volume of 24 hour Urine

759

0.76

1.79

1.8

2.2

1947.45

1988.07

0.16

692

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.89

1.78

1.7

1.3

256.65

327.84

umol/24h

0.94

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

193

1.51

1.77

1.0

88.56

76.47

ug/l

1.14

163

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.86

1.72

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

178

971

1.21

1.71

1.3

820.78

537.19

u/l

0.44

168

918

(40758358) Immune stain study

2.11

1.66

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

117

1.64

1.65

2.7

2.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.35

1.64

1.1

1.0

419.00

213.53

pmol/l

—

(21494814) CD8 cells/100 lymphocytes in Specimen

410

1.32

1.62

2.2

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

199

1105

1.19

1.61

1.7

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.75

1.59

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

186

1031

1.20

1.54

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

156

0.51

1.54

5.9

6.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

781

5614

0.92

1.54

1.9

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

259

1477

1.16

1.54

1.4

8.92

7.66

mmol/l

3.78

246

1431

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.05

1.52

3.8

3.2

—

(3017509) Phencyclidine [Presence] in Urine

147

1.53

1.49

1.4

—

(3033799) Differential panel - Peritoneal fluid

330

1.34

1.49

1.7

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

191

1.46

1.47

1.4

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

383

1.31

1.46

2.7

2.3

157.91

151.54

nmol/l

0.20

315

(3052592) Norovirus Ag [Presence] in Stool

197

1.45

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

127

1.56

1.45

6.9

6.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.38

1.44

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

281

1.37

1.44

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

291

1684

1.14

1.44

1.2

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.31

1.43

2.0

3.9

—

(40760409) HLA-A [Type] by High resolution

2.57

1.42

1.1

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.57

1.42

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

2.57

1.42

1.1

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

2.57

1.42

1.0

—

9748.30

—

(40763590) HLA-DQ beta [Type]

2.57

1.42

1.1

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.28

1.42

1.1

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.84

1.41

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

237

1.40

1.41

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

164

910

1.19

1.38

1.0

1.1

0.42

1.87

u/ml

2.52

197

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.78

1.38

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1539

10748

0.94

1.37

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

250

1.38

1.36

1.4

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

105

558

1.25

1.35

1.1

1282.51

1412.75

miu/ml

0.64

105

558

(3020891) Body temperature

604

4359

0.92

1.34

6.2

4.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

162

1.47

1.34

3.4

3.3

—

(3042631) Mycobacterium sp identified in Specimen

275

1595

1.14

1.34

3.0

2.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.52

1.33

1.0

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.79

1.33

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.79

1.33

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.70

1.33

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

199

1128

1.17

1.32

1.5

1.3

0.92

0.94

g/l

0.37

199

1121

(3021901) Oxygen saturation in Capillary blood

352

2082

1.12

1.27

2.8

2.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.62

1.24

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

210

0.63

1.23

4.3

4.6

47.23

48.27

ug/min

0.03

172

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

139

770

1.20

1.23

1.3

1.2

14.42

14.17

u/l

0.03

131

725

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.21

1.21

1.3

—

(3016135) IgD [Mass/volume] in Serum

2.21

1.21

1.3

3.5

73.61

36.65

mg/l

—

(3044007) Cell count panel - Peritoneal fluid

302

1.32

1.21

1.6

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

1.19

0.0

1.0

—

64.65

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.63

1.18

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.82

1.17

1.1

0.01

3.11

u/ml

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.77

1.16

1.1

10.47

9.00

u/ml

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.74

1.16

3.3

2.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

198

0.63

1.15

6.7

6.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

196

1.38

1.15

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.44

1.15

1.0

1.1

—

(3013862) HLA-DP [Type]

2.44

1.15

1.1

1.0

—

(3004775) Volume in Urine collected for unspecified duration

116

920

0.83

1.14

2.3

1.9

664.63

692.90

0.35

576

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.97

1.14

1.1

244.55

281.85

nmol/l

0.17

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

125

1.48

1.12

1.5

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.32

1.11

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

490

1.23

1.10

1.1

—

(3016750) Collection duration of Urine

684

0.81

1.09

2.1

1.9

506.93

502.84

min

0.20

463

(3046861) Legionella sp Ag [Presence] in Urine

0.48

1.08

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

2.11

1.03

1.0

1.1

—

(3013762) Body weight Measured

1.95

1.02

1.1

—

(3008607) Semen analysis panel

1.54

0.97

1.3

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

189

0.66

0.96

1.3

1.4

12.00

11.33

—

112

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.76

0.94

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

415

0.78

0.93

1.3

1.4

53.30

62.81

0.98

353

(3026692) Albumin [Mass/volume] in Peritoneal fluid

251

1.29

0.92

1.7

1.2

12.59

13.51

g/l

0.32

190

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

2.21

0.92

1.0

9.30

12.88

u/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

435

1.22

0.92

1.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

143

1.39

0.90

1.1

1.6

—

63.63

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

280

1676

1.11

0.90

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.69

0.89

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.09

0.89

1.0

1.1

1.83

1.68

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

342

1.24

0.87

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

105

1.45

0.87

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.83

0.85

1.5

2.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

156

1.36

0.85

1.9

1.7

1.16

1.19

mmol/l

1.11

144

(3024316) Viscosity of Plasma

1.63

0.85

1.2

1.6

1.50

1.71

mpas

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.69

0.83

3.6

3.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

124

710

1.16

0.82

1.2

257.25

401.61

u/l

1.12

108

668

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

357

1.22

0.82

3.4

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

357

1.22

0.82

3.4

2.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

841

5865

0.95

0.82

1.4

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.81

0.0

1.1

—

31.24

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.89

0.81

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

200

1.29

0.76

1.5

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

494

3058

1.07

0.76

5.6

4.1

3.85

3.89

mmol/l

1.30

488

3038

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.93

0.76

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.51

0.75

1.1

7.06

14.86

u/l

1.15

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

242

1.26

0.75

1.3

1.2

0.68

35.54

mg/l

1.28

178

(40758292) HTLV I+II Ab panel - Serum

178

1.30

0.73

1.5

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

257

1554

1.10

0.72

1.6

7.77

7.51

mmol/l

1.12

246

1497

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.78

0.72

1.1

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

230

1385

1.10

0.71

1.4

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.58

0.69

1.0

—

(4212803) Bone marrow aspirate examination

105

1.39

0.69

1.1

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

205

0.74

0.68

1.1

1.58

1.65

mmol/l

0.08

112

(3011544) Albumin [Mass/volume] in Pleural fluid

128

0.67

0.68

1.4

1.2

17.94

17.74

g/l

0.03

116

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.54

0.66

1.1

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.48

0.65

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1248

8563

0.96

0.65

2.3

2.0

10.92

12.02

nmol/l

4.42

1102

7750

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.45

0.64

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.63

0.62

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.61

0.0

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

365

1.18

0.60

1.2

1.3

41.60

22.00

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.80

0.59

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.80

0.59

1.3

1.2

2.27

2.35

mmol/24h

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

466

2911

1.06

0.59

1.8

1.7

—

(3017569) Oxygen content in Arterial blood

384

1.17

0.59

2.9

2.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1032

7090

0.96

0.59

1.5

1.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.56

0.57

1.0

1.3

1.52

1.32

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

312

1.19

0.57

1.1

61.72

60.04

u/ml

0.06

301

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

726

4597

1.05

0.56

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.53

0.55

1.3

1.9

26.87

16.10

nmol/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

338

1.17

0.55

2.8

2.2

130.10

92.50

ng/l

0.84

147

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

116

1.31

0.54

1.1

26.44

20.22

u/l

0.89

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.60

0.53

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.53

0.52

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

489

1.14

0.52

4.9

3.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

366

1.16

0.50

1.1

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

221

0.81

0.47

2.7

2.4

17.95

30.43

mg/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

202

1436

0.93

0.45

1.7

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

158

1134

0.92

0.45

1.3

1.4

29.09

32.99

nmol/l

1.10

142

1061

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

266

1.17

0.44

1.3

1.1

—

(36303858) Crystals [Presence] in Urine

1.65

0.44

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.58

0.42

8.4

9.7

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.58

0.42

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

267

1.17

0.42

1.4

1.3

39.13

38.65

0.03

190

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.42

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.32

0.42

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

154

1102

0.92

0.42

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.39

0.42

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.29

0.41

1.0

1.2

1.86

1.74

umol/24h

0.11

(3013293) Extractable nuclear Ab [Presence] in Serum

182

1.20

0.41

1.7

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1416

9156

1.02

0.38

1.7

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

160

987

1.07

0.36

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

248

1.15

0.34

5.8

6.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

162

0.82

0.34

1.0

—

(3035880) pH of Pleural fluid

589

0.91

0.34

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

229

1600

0.95

0.34

5.1

6.4

7.98

7.07

mmol/l

0.65

164

1314

(3003157) Bacteria [#/volume] in Mother's milk

1.32

0.33

4.0

5.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

373

0.89

0.33

2.1

1.9

—

(3019977) pH of Arterial blood

108

660

1.08

0.32

3.5

2.5

7.42

7.43

0.36

269

(3016031) Almond IgE Ab [Units/volume] in Serum

1.30

0.32

1.0

0.10

0.67

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

169

1.17

0.32

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

136

0.83

0.27

1.1

1.2

0.28

1.68

mmol/l

—

(3022475) Manganese [Moles/volume] in Blood

1.23

0.27

1.2

—

(3001729) Color of Synovial fluid

107

0.80

0.27

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

554

3563

1.03

0.26

5.3

3.9

1.34

1.44

mmol/l

1.62

544

3509

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

267

1.12

0.26

1.9

2.5

7.49

7.27

mmol/l

0.14

130

(3009677) Dengue virus Ab [Presence] in Serum

0.74

0.24

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.38

0.24

1.2

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.27

0.23

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

1111

0.95

0.22

1.8

1.6

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

939

6326

0.98

0.21

7.7

6.4

24.44

24.43

mmol/l

0.03

902

5977

(3047181) Lactate [Moles/volume] in Blood

502

3240

1.03

0.21

4.0

4.9

1.28

1.26

mmol/l

0.14

461

2785

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

215

0.89

0.20

1.5

2.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.18

0.18

1.1

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

576

1.06

0.18

3.5

3.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

636

0.95

0.18

1.4

3.63

3.45

0.05

163

(3044242) Glucose [Moles/volume] in Arterial blood

454

1.06

0.17

3.2

2.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

308

1.07

0.16

1.3

1.2

3.34

3.55

mmol/l

0.20

282

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

243

1563

1.03

0.15

1.5

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.85

0.15

2.3

2.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

136

866

1.04

0.15

1.0

0.49

0.58

u/ml

0.20

163

(3010937) Rubella virus Ab [Presence] in Serum

105

1.13

0.14

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

463

3007

1.02

0.14

2.0

2.2

128.95

130.23

g/l

0.48

292

2342

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

320

2165

0.98

0.14

1.8

175.87

190.61

pmol/l

1.83

306

2054

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

234

1.07

0.13

1.4

1.9

1.78

4.57

ug/l

0.82

155

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.17

0.12

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

429

2791

1.02

0.12

1.3

2.89

4.00

ug/l

2.76

380

2538

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

176

1196

0.97

0.11

1.4

1.5

36.94

31.99

0.87

105

731

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.13

0.10

5.4

3.9

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.13

0.09

1.0

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.04

0.08

1.5

1.1

—

mmol/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

169

1097

1.02

0.07

1.3

6.35

6.10

mmol/l

0.56

162

1010

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

330

0.96

0.06

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

491

3279

0.99

0.06

1.6

44.90

42.00

nmol/l

1.50

473

3222

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

496

0.97

0.05

2.8

3.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

157

1.05

0.05

2.4

2.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

120

0.94

0.04

1.6

1.5

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.10

0.04

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

343

0.98

0.01

1.4

1.3

56.71

54.39

0.17

291

(40768795) Lymph node Pathology biopsy report

227

1497

1.00

0.00

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

327

1.01

0.00

1.4

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

424

1.00

0.00

1.3

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

202

1.02

0.00

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.03

0.00

1.1

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

151

1.01

0.00

1.3

2.5

6.70

6.78

mmol/l

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

0.0

1.0

—

12.46

—

(3029088) Stachybotrys chartarum IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3033016) Trichoderma viride IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.91

0.00

1.0

7.00

8.64

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3034610) Cladosporium cladosporioides IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.91

0.00

1.0

35.19

36.54

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.99

-0.00

1.8

1.3

350.40

492.27

nmol/l

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

1.80

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

1.2

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS – Follow-up examination after treatment for conditions other than malignant neoplasms

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Follow-up examination after treatment for conditions other than malignant neoplasms

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Follow-up examination after treatment for conditions other than malignant neoplasms (Z21_FOLLOW__EXAM_TREAT_CONDI_OTH_MALIG_NEOPLASMS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints